10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 001-35637

ASTA FUNDING, INC.

(Exact name of registrant as specified in its charter)

Delaware	22-3388607
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
210 Sylvan Ave., Englewood Cliffs, New Jersey	07632
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number: (201) 567-5648

Former name, former address and former fiscal year, if changed since last report: N/A

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of August 5, 2013, the registrant had approximately 12,967,039 common shares outstanding.

ASTA FUNDING, INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q

Part I. Financial Information	3
Item 1. Financial Statements	3
Condensed Consolidated Balance Sheets as of June 30, 2013 and September 30, 2012 (unaudited)	3
Condensed Consolidated Statements of Operations for the three and nine month periods ended June 30, 2013 and 2012 (unaudited)	4
Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and nine month periods ended June 30, 2013 and 2012 (unaudited)	5
Condensed Consolidated Statement of Stockholders’ Equity for the nine month period ended June  30, 2013 (unaudited)	6
Condensed Consolidated Statements of Cash Flows for the nine month periods ended June  30, 2013 and 2012 (unaudited)	7
Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3. Quantitative and Qualitative Disclosures about Market Risk	39
Item 4. Controls and Procedures	39
Part II. Other Information	40
Item 1. Legal Proceedings	40
Item 1A. Risk Factors	40
Item 6. Exhibits	41
Signatures	42
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

ASTA FUNDING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2013			September 30, 2012
	(Unaudited)			(Unaudited)
ASSETS
Cash and cash equivalents	$	38,252,000		$	4,953,000
Investments:
Available-for-sale		58,336,000			58,712,000
Certificates of deposit		8,764,000			42,682,000
Restricted cash		1,067,000			1,088,000
Consumer receivables acquired for liquidation (at net realizable value)		62,594,000			86,887,000
Other investments, net		32,297,000			18,596,000
Due from third party collection agencies and attorneys		1,240,000			2,042,000
Prepaid and income taxes receivable		1,675,000			2,057,000
Furniture and equipment, net		1,096,000			821,000
Deferred income taxes, net		10,944,000			10,410,000
Other assets		7,285,000			4,916,000
Total assets	$	223,550,000		$	233,164,000
LIABILITIES
Non-recourse debt	$	54,250,000		$	61,463,000
Other liabilities		1,816,000			2,920,000
Dividends payable		—			260,000
Total liabilities		56,066,000			64,643,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding — none		—			—
Common stock, $.01 par value; authorized 30,000,000 shares; issued — 14,910,777 at June 30, 2013 and 14,778,956 at September 30, 2012; and outstanding — 12,967,039 at June 30, 2013 and 13,006,918 at September 30, 2012		149,000			148,000
Additional paid-in capital		78,624,000			77,024,000
Retained earnings		107,006,000			107,303,000
Accumulated other comprehensive (loss) income, net of tax		(697,000	)		241,000
Treasury stock (at cost) 1,943,738 shares at June 30, 2013 and 1,772,038 shares at September 30, 2012		(17,805,000	)		(16,226,000	)
Non-controlling interest		207,000			31,000
Total stockholders’ equity		167,484,000			168,521,000
Total liabilities and stockholders’ equity	$	223,550,000		$	233,164,000

See accompanying notes to condensed consolidated financial statements

3

ASTA FUNDING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended June 30, 2013			Three Months Ended June 30, 2012		Nine Months Ended June 30, 2013		Nine Months Ended June 30, 2012
Revenues:
Finance income, net	$	10,003,000		$	10,501,000	$	26,756,000	$	30,761,000
Other income (includes $17,000 and $134,000 during the three months ended June 30, 2013 and 2012, respectively; and $192,000 and $251,000 during the nine months ended June 30, 2013 and 2012, respectively, of accumulated other comprehensive income reclassifications for unrealized net gains on available for sale securities.)		2,665,000			1,070,000		6,549,000		2,719,000
		12,668,000			11,571,000		33,305,000		33,480,000
Expenses:
General and administrative		6,545,000			5,694,000		17,926,000		16,492,000
Interest		518,000			619,000		1,621,000		1,939,000
Impairments of consumer receivables acquired for liquidation		10,148,000			122,000		12,351,000		733,000
		17,211,000			6,435,000		31,898,000		19,164,000
(Loss) income before income tax		(4,543,000	)		5,136,000		1,407,000		14,316,000
Income tax (benefit) expense		(1,859,000	)		2,071,000		498,000		5,765,000
Net (loss) income		(2,684,000	)		3,065,000		909,000		8,551,000
Less: net income attributable to non-controlling interest		53,000			17,000		176,000		66,000
Net (loss) income attributable to Asta Funding, Inc.	$	(2,737,000	)	$	3,048,000	$	733,000	$	8,485,000
Net (loss) income per share attributable to Asta Funding, Inc.:
Basic	$	(0.21	)	$	0.22	$	0.06	$	0.59
Diluted	$	(0.21	)	$	0.21	$	0.06	$	0.58
Weighted average number of common shares outstanding:
Basic		12,954,455			14,170,575		12,946,521		14,440,224
Diluted		12,954,455			14,429,043		13,217,903		14,683,641

See accompanying notes to condensed consolidated financial statements

4

ASTA FUNDING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited)

	Three Months Ended June 30, 2013			Three Months Ended June 30, 2012			Nine Months Ended June  30, 2013			Nine Months Ended June 30, 2012
Comprehensive (loss) income is as follows:
Net (loss) income	$	(2,684,000	)	$	3,065,000		$	909,000		$	8,551,000
Net unrealized securities (loss) / gain, net of tax benefit / (taxes) of $415,000 and ($74,000), during the three month periods ended June 30, 2013 and 2012, respectively, and $543,000 and ($337,000), during the nine month periods ended June 30, 2013 and 2012, respectively.		(631,000	)		110,000			(822,000	)		500,000
Reclassification adjustments for securities sold, net of tax benefit of $5,000 and $54,000, during the three month periods ended June 30, 2013 and 2012, respectively, and $76,000 and $101,000, during the nine month periods ended June 30, 2013 and 2012, respectively.		(12,000	)		(80,000	)		(116,000	)		(150,000	)
Other comprehensive (loss) income		(643,000	)		30,000			(938,000	)		350,000
Total comprehensive (loss) income	$	(3,327,000	)	$	3,095,000		$	(29,000	)	$	8,901,000

See accompanying notes to condensed consolidated financial statements

5

ASTA FUNDING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited)

	Common Stock				Additional						Accumulated Other						Non-		Total
	Issued				Paid-in			Retained			Comprehensive			Treasury			Controlling		Stockholders’
	Shares		Amount		Capital			Earnings			Income (Loss)			Stock (1)			Interest		Equity
Balance, September 30, 2012		14,778,956	$	148,000	$	77,024,000		$	107,303,000		$	241,000		$	(16,226,000	)	$	31,000	$	168,521,000
Exercise of options		29,500		—		103,000														103,000
Stock based compensation expense						1,498,000														1,498,000
Restricted stock		102,321		1,000		(1,000	)													—
Dividends									(1,030,000	)										(1,030,000	)
Purchase of treasury stock															(1,579,000	)				(1,579,000	)
Net income									733,000									176,000		909,000
Unrealized loss on marketable securities												(938,000	)							(938,000	)
Balance, June 30, 2013		14,910,777	$	149,000	$	78,624,000		$	107,006,000		$	(697,000	)	$	(17,805,000	)	$	207,000	$	167,484,000

(1) Treasury shares are as follows: September 30, 2012, 1,772,038; Purchase of treasury stock, 171,700; June 30, 2013, 1,943,738.

See accompanying notes to condensed consolidated financial statements

6

ASTA FUNDING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended June 30, 2013			Nine Months Ended June 30, 2012
Cash flows from operating activities:
Net income	$	909,000		$	8,551,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		450,000			410,000
Deferred income taxes		85,000			1,375,000
Impairments of consumer receivables acquired for liquidation		12,351,000			733,000
Stock based compensation		1,498,000			1,181,000
Gain on sale of available-for-sale securities		(192,000	)		(251,000	)
Changes in:
Other assets		(2,369,000	)		(370,000	)
Due from third party collection agencies and attorneys		802,000			53,000
Prepaid and income taxes receivable		382,000			4,390,000
Other liabilities		(1,104,000	)		(392,000	)
Net cash provided by operating activities		12,812,000			15,680,000
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation		(3,340,000	)		(2,675,000	)
Principal collected on consumer receivables acquired for liquidation		14,850,000			23,344,000
Principal collected on consumer receivable accounts represented by account sales		432,000			53,000
Purchase of available-for-sale securities		(29,907,000	)		(57,128,000	)
Proceeds from sale of available-for-sale securities		28,918,000			13,405,000
Purchase of certificates of deposit		—			(25,050,000	)
Proceeds from maturities of certificates of deposits		33,918,000			6,544,000
Other investments – advances		(22,863,000	)		(14,906,000	)
Other investments – receipts		9,162,000			1,870,000
Capital expenditures		(725,000	)		(63,000	)
Net cash provided by (used in) investing activities		30,445,000			(54,606,000	)
Cash flows from financing activities:
Proceeds from exercise of options		103,000			61,000
Purchase of treasury stock		(1,579,000	)		(13,106,000	)
Change in restricted cash		21,000			(199,000	)
Dividends paid		(1,290,000	)		(875,000	)
Repayments of non-recourse debt		(7,213,000	)		(7,321,000	)
Net cash used in financing activities		(9,958,000	)		(21,440,000	)
Net increase (decrease) in cash and cash equivalents		33,299,000			(60,366,000	)
Cash and cash equivalents at beginning of period		4,953,000			84,347,000
Cash and cash equivalents at end of period	$	38,252,000		$	23,981,000
Supplemental disclosure of cash flow information:
Cash paid during the period
Interest	$	1,645,000		$	1,961,000
Income taxes	$	—		$	2,000

See accompanying notes to condensed consolidated financial statements

7

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1: Business and Basis of Presentation

Business

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), Pegasus Funding, LLC (“Pegasus”) and other subsidiaries, not all wholly owned, and not considered material (the “Company”) is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged-off receivables, semi-performing receivables and performing receivables. The primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Performing receivables are accounts where the debtor is making regular monthly payments that may or may not have been delinquent in the past. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of the Company’s distressed consumer receivables are MasterCard(R), Visa(R), other credit card accounts, and telecommunication accounts which were charged-off by the issuers for non-payment. The Company acquires these portfolios at substantial discounts from their face values. The discounts are based on the characteristics (issuer, account size, debtor residence and age of debt) of the underlying accounts of each portfolio.

In addition, the Company, through majority-owned subsidiaries Pegasus Funding, LLC, and BP Case Management, LLC, invests in funding personal injury and matrimonial claims, respectively.

Basis of Presentation

The condensed consolidated balance sheet as of June 30, 2013, the condensed consolidated statements of operations for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statements of comprehensive (loss) income for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statement of stockholders’ equity as of and for the nine months ended June 30, 2013 and the condensed consolidated statements of cash flows for the nine month periods ended June 30, 2013 and 2012 are unaudited. The September 30, 2012 financial information included in this report has been extracted from our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly our financial position at June 30, 2013 and September 30, 2012, the results of operations for the nine and three month periods ended June 30, 2013 and 2012 and cash flows for the nine month periods ended June 30, 2013 and 2012 have been made. The results of operations for the nine and three month periods ended June 30, 2013 and 2012 are not necessarily indicative of the operating results for any other interim period or the full fiscal year.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2012 filed with the SEC.

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

8

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1: Business and Basis of Presentation (continued)

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02 “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”. The amendments require an entity to present, either in the income statement or the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required under U.S. Generally Accepted Accounting Principles (“GAAP”) to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety, an entity is required to cross-reference to other disclosures that might provide additional details about the amounts. This ASU was effective for annual and interim periods beginning January 1, 2013. Adoption of the ASU did not have a significant effect on the Company’s consolidated financial statements (see Note 3: Investments).

In December 2011, the FASB issued ASU No. 2011-12, amended ASC Topic 220 “Comprehensive Income.” The amendments defer certain disclosure requirements regarding reclassifications within ASU No. 2011-05, until the FASB can deliberate further on these requirements. The amendments in this update are effective for the annual period beginning on or after December 15, 2012 and must be applied retrospectively. The Company has chosen to early-adopt ASU 2011-12 and implementation of this guidance has not had a material effect on the Company’s consolidated financial statements.

Concentration of Credit Risk – Cash

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with seven banks at June 30, 2013 that exceeded the balance insured by the FDIC by approximately $35.2 million.

Subsequent Events

The Company has evaluated events and transactions occurring subsequent to the Condensed Balance Sheet date of June 30, 2013, for items that should potentially be recognized or disclosed in these financial statements. On August 7, 2013, the Company entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with the Bank of Montreal (“BMO”) as an Amendment to the Receivables Financing Agreement. See Note 16 for more information.

Note 2: Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

9

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 3: Investments

Available-for-Sale

Investments classified as available-for-sale at June 30, 2013 and September 30, 2012 consist of the following:

Mutual Funds	Cost		Unrealized Gains		Unrealized Losses			Fair Value
June 30, 2013	$	55,489,000	$	—	$	(1,153,000	)	$	58,336,000
September 30, 2012	$	58,308,000	$	404,000	$	—		$	58,712,000

The available-for-sale investments did not have any contractual maturities. The Company sold three investments during the nine month period ended June 30, 2013, with an aggregate realized gain of $192,000. The Company sold one investment during the three month period ended June 30, 2013, with a realized gain of $17,000. Additionally, the Company received $225,000 in capital gain distribution dividends during the first quarter of fiscal year 2013, which is included in other income. The Company recorded a total of $417,000 in income related to its available-for-sale investments during the first nine months of fiscal year 2013. The Company sold two investments during the nine months ended June 30, 2012, resulting in a realized gain of approximately $251,000.

At June 30, 2013, all six of the Company’s investments were in an unrealized loss position, each of which had current unrealized losses existing for 12 months or less. At September 30, 2012, there were six investments in an unrealized gain position. All of these securities are considered to be acceptable credit risks. Based on the evaluation of the available evidence, including recent changes in market rates and credit rating information, management believes the aggregate decline in fair value of these instruments is temporary. In addition, management has the ability, but does not believe it will be required, to sell these investment securities for a period of time sufficient to allow for an anticipated recovery or maturity. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period in which the other-than-temporary impairment is identified.

Unrealized holding gains and losses on available-for-sale securities are included in other comprehensive income within stockholders’ equity. Realized gains (losses) on available-for-sale securities are included in other income and, when applicable, are reported as a reclassification adjustment in other comprehensive income.

Certificates of Deposit

Certificates of deposit consist of the following:

	June 30,		September 30,
	2013		2012
Certificates of deposit in banks	$	8,764,000	$	42,682,000

Certificates are generally nonnegotiable and nontransferable, and may incur substantial penalties for withdrawal prior to maturity, which will be within one year. The Company liquidated two certificates of deposit of an aggregate of approximately $33,918,000 (plus accrued interest) during the nine month period ended June 30, 2013.

10

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4: Consumer Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at their net estimated realizable value and consist primarily of defaulted consumer loans to individuals throughout the country and in Central and South America.

The Company accounts for its investments in consumer receivable portfolios, using either:

• the interest method; or

• the cost recovery method.

The Company accounts for its investment in finance receivables using the interest method, under the guidance of FASB Accounting Standards Codification (“ASC”), Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality, (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision.

Once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller). ASC 310 requires that the excess of the contractual cash flows over expected cash flows not be recognized as an adjustment of revenue or expense or on the balance sheet. ASC 310 initially freezes the internal rate of return, referred to as IRR, estimated when the accounts receivable are purchased, as the basis for subsequent impairment testing. Significant increases in actual or expected future cash flows may be recognized prospectively through an upward adjustment of the IRR over a portfolio’s remaining life. Any increase to the IRR then becomes the new benchmark for impairment testing. Rather than lowering the estimated IRR if the collection estimates are not received or projected to be received, the carrying value of a pool would be impaired, or written down, to maintain the then current IRR. Under the interest method, income is recognized on the effective yield method based on the actual cash collected during a period and future estimated cash flows and timing of such collections and the portfolio’s cost. Revenue arising from collections in excess of anticipated amounts attributable to timing differences is deferred until such time as a review results in a change in the expected cash flows. The estimated future cash flows are reevaluated quarterly.

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.

The Company has liquidating experience in the fields of distressed credit card receivables, telecommunication receivables, consumer loan receivables, retail installment contracts, consumer receivables, litigation-related medical accounts, and auto deficiency receivables. The Company uses the interest method for accounting for asset acquisitions within these classes of receivables when it believes it can reasonably estimate the timing of the cash flows. In those situations where the Company diversifies its acquisitions into other asset classes in which the Company does not possess the same expertise or history, or the Company cannot reasonably estimate the timing of the cash flows, the Company utilizes the cost recovery method of accounting for those portfolios of receivables. At June 30, 2013, approximately $9.1 million of the consumer receivables acquired for liquidation are accounted for using the interest method, while approximately $53.5 million are accounted for using the cost recovery method, of which $46.3 million is concentrated in one portfolio, a $300 million portfolio purchase in March 2007 (the “Portfolio Purchase”).

11

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4: Consumer Receivables Acquired for Liquidation (continued)

The Company aggregates portfolios of receivables acquired sharing specific common characteristics which were acquired within a given quarter. The Company currently considers for aggregation portfolios of accounts, purchased within the same fiscal quarter, that generally meet the following characteristics:

• same issuer/originator;

• same underlying credit quality;

• similar geographic distribution of the accounts;

• similar age of the receivable; and

• same type of asset class (credit cards, telecommunication, etc.).

The Company uses a variety of qualitative and quantitative factors to estimate collections and the timing thereof. This analysis includes the following variables:

• the number of collection agencies previously attempting to collect the receivables in the portfolio;

• the average balance of the receivables, as higher balances might be more difficult to collect, while low balances might not be cost effective to collect;

• the age of the receivables, as older receivables might be more difficult to collect or might be less cost effective. On the other hand, the passage of time, in certain circumstances, might result in higher collections due to changing life events of some individual debtors;

• past history of performance of similar assets;

• time since charge-off;

• payments made since charge-off;

• the credit originator and its credit guidelines;

• the Company’s ability to analyze accounts and resell accounts that meet its criteria for resale;

• the locations of the debtors, as there are better states to attempt to collect in and, ultimately, the Company has better predictability of the liquidations and the expected cash flows. Conversely, there are states where the liquidation rates are not as favorable and that is factored into the Company’s cash flow analysis;

• financial condition of the seller;

• jobs or property of the debtors found within portfolios. In the Company’s business model, this is of particular importance as debtors with jobs or property are more likely to repay their obligation and, conversely, debtors without jobs or property are less likely to repay their obligation; and

• the ability to obtain timely customer statements from the original issuer.

The Company obtains and utilizes, as appropriate, input, including, but not limited to, monthly collection projections and liquidation rates from our third party collection agencies and attorneys, as further evidentiary matter, to assist in evaluating and developing collection strategies and in evaluating and modeling the expected cash flows for a given portfolio.

12

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4: Consumer Receivables Acquired for Liquidation (continued)

The following tables summarize the changes in the balance sheet of the investment in receivable portfolios during the following periods.

	For the Nine Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	12,326,000		$	74,561,000		$	86,887,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collection of consumer receivables acquired for liquidation		(26,901,000	)		(13,113,000	)		(40,014,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(987,000	)		(1,037,000	)		(2,024,000	)
Impairment		(2,203,000	)		(10,148,000	)		(12,351,000	)
Finance income recognized (1)		23,531,000			3,225,000			26,756,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		84.4	%		22.8	%		63.6	%

(1) Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales which occurred in the third quarter.

	For the Nine Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	31,193,000		$	84,002,000		$	115,195,000
Acquisitions of receivable portfolios		1,278,000			1,397,000			2,675,000
Net cash collections from collection of consumer receivables acquired for liquidation		(38,550,000	)		(15,519,000	)		(54,069,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(89,000	)		—			(89,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(733,000	)		—			(733,000	)
Finance income recognized (1)		28,641,000			2,120,000			30,761,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		74.1	%		13.7	%		56.8	%

(1) Includes approximately $27.4 million derived from fully amortized portfolios.

13

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4: Consumer Receivables Acquired for Liquidation (continued)

	For the Three Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	6,813,000		$	68,011,000		$	74,824,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collections of consumer receivables acquired for liquidation		(8,611,000	)		(4,807,000	)		(13,418,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(970,000	)		(1,037,000	)		(2,007,000	)
Impairment		—			(10,148,000	)		(10,148,000	)
Finance income recognized (1)		8,534,000			1,469,000			10,003,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		89.1	%		25.1	%		64.8	%

(1) Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

	For the Three Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	24,897,000		$	76,939,000		$	101,836,000
Net cash collections from collections of consumer receivables acquired for liquidation		(12,672,000	)		(5,792,000	)		(18,464,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(11,000	)		—			(11,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(122,000	)		—			(122,000	)
Finance income recognized (1)		9,648,000			853,000			10,501,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		76.1	%		14.7	%		56.8	%

(1) Includes approximately $9.6 million derived from fully amortized portfolios.

As of June 30, 2013, the Company had $62.6 million in Consumer Receivables acquired for Liquidation, of which $9.1 million are being accounted for on the interest method. Based upon current projections, net cash collections applied to principal for interest method portfolios will be as follows for the twelve months in the periods ending:

September 30, 2013 (three months ending)	$	2,294,000
September 30, 2014		3,389,000
September 30, 2015		952,000
September 30, 2016		736,000
September 30, 2017		576,000
September 30, 2018		485,000
September 30, 2019		420,000
September 30, 2020		254,000
Total	$	9,106,000

14

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4: Consumer Receivables Acquired for Liquidation (continued)

Accretable yield represents the amount of income the Company can expect to generate over the remaining life of its existing portfolios based on estimated future net cash flows as of June 30, 2013. The Company adjusts the accretable yield upward when it believes, based on available evidence, that portfolio collections will exceed amounts previously estimated. Changes in accretable yield for the nine months and three months ended June 30, 2013 and 2012 are as follows:

	For the Nine Months Ended June 30,
	2013			2012
Balance at beginning of period	$	2,086,000		$	7,473,000
Income recognized on finance receivables		(23,531,000	)		(28,536,000	)
Additions representing expected revenue from purchases		983,000			362,000
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		21,874,000			25,880,000
Balance at end of period	$	1,412,000		$	3,339,000
	For the Three Months Ended June 30,
	2013			2012
Balance at beginning of period	$	942,000		$	6,107,000
Income recognized on finance receivables		(8,534,000	)		(9,543,000	)
Additions representing expected revenue from purchases		983,000			—
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		8,021,000			8,615,000
Balance at end of period	$	1,412,000		$	3,339,000

During both the three and nine month period ended June 30, 2013, the Company purchased $53.5 million of face value receivables at a cost of approximately $3.3 million. During the nine month period ended June 30, 2012, the Company purchased $6.0 million of face value receivables at a cost of $2.7 million. There were no portfolio purchases during the three month period ended June 30, 2012. The current fiscal year purchases were for credit card receivables, while those in the prior fiscal year were in the litigation related category.

The following table summarizes collections on a gross basis less commissions and fees for the nine and three month periods ended June 30, 2013 and 2012, respectively:

	For the Nine Months Ended June 30,
	2013		2012
Gross collections (1)	$	66,371,000	$	83,379,000
Less: commissions and fees (2)		24,333,000		29,221,000
Net collections	$	42,038,000	$	54,158,000
	For the Three Months Ended June 30,
	2013		2012
Gross collections (1)	$	23,432,000	$	28,023,000
Less: commissions and fees (2)		8,007,000		9,548,000
Net collections	$	15,425,000	$	18,475,000

(1) Gross collections include: collections by third-party collection agencies and attorneys, collections from our internal efforts and collections represented by account sales.

(2) Commissions and fees are the contractual commission earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. Includes a 3% fee charged by a servicer on gross collections in connection with the Portfolio Purchase. Such arrangement was consummated in December 2007. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

15

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 5: Other Investments

Personal Injury Claims

On December 28, 2011, the Company, through an indirect subsidiary, APH, entered into a joint venture with Pegasus Legal Funding LLC (“PLF”) in the operating subsidiary of Pegasus. Pegasus purchases interests in claims from claimants who are a party to a personal injury litigation, with the expectation of a settlement in the future. Pegasus advances, to each claimant, funds, on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company, through Pegasus, earned $2.3 million and $4.9 million, respectively, in interest and fees for the three and nine month periods ended June 30, 2013, compared to $0.4 million and $1.0 million for the three and nine month periods ended June 30, 2012. The Company had a net invested balance of $32.3 million on June 30, 2013 and a $13.0 million net invested balance on June 30, 2012. The collections yielded net income attributable to non-controlling interest of $176,000 and $53,000, respectively, for the nine and three month periods ended June 30, 2013, compared to $66,000 and $17,000, respectively, for the nine and three month periods ended June 30, 2012.

Matrimonial Claims (included in Other Assets)

On May 18, 2012, the Company formed BP Case Management, LLC (“BPCM”), a joint venture with California-based Balance Point Divorce Funding LLC (“BP Divorce Funding”). BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provides a $1.0 million revolving line of credit to partially fund BP Divorce Funding’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of twenty-four months. The revolving line of credit is collateralized by BP Divorce Funding’s profit share in BPCM and other assets. As of June 30, 2013, the Company’s investment in cases through BPCM was approximately $989,000. The Company recognized $0 in revenue for the three month periods ended June 30, 2013 and 2012. The Company recognized $0 in revenue for the nine month period ended June 30, 2013 compared to $165,000 for the nine month period ended June 30, 2012.

Note 6: Furniture and Equipment

Furniture and equipment consist of the following as of the dates indicated:

	June 30, 2013		September 30, 2012
Furniture	$	310,000	$	310,000
Equipment		3,623,000		3,470,000
Software		1,210,000		638,000
Leasehold improvements		99,000		99,000
		5,242,000		4,517,000
Less accumulated depreciation and amortization		4,146,000		3,696,000
	$	1,096,000	$	821,000

16

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 7: Non-Recourse Debt

Receivables Financing Agreement

In March 2007, Palisades XVI borrowed approximately $227 million under the Receivables Financing Agreement, as amended in July 2007, December 2007, May 2008, February 2009 and October 2010, in order to finance the Portfolio Purchase. The Portfolio Purchase had a purchase price of $300 million (plus 20% of net payments after Palisades XVI recovers 150% of its purchase price plus cost of funds, which recovery has not yet occurred). Prior to the modification, discussed below, the debt was full recourse only to Palisades XVI and accrued interest at the rate of approximately 170 basis points over LIBOR. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments to the Receivables Financing Agreement as discussed below. Proceeds received as a result of the net collections from the Portfolio Purchase are applied to interest and principal of the underlying loan. The Portfolio Purchase is serviced by Palisades Collection LLC, which has engaged unaffiliated subservicers for a majority of the Portfolio Purchase.

Since the inception of the Receivables Financing Agreement, amendments have been signed to revise various terms of the Receivables Financing Agreement. On October 26, 2010, Palisades XVI entered into the Fifth Amendment to the Receivables Financing Agreement (the “Fifth Amendment”). The effective date of the Fifth Amendment was October 14, 2010. The Fifth Amendment (i) extends the expiration date of the Receivables Financing Agreement to April 14, 2014; (ii) reduces the minimum monthly total payment to $750,000; (iii) accelerated the Company’s guaranty credit enhancement of $8,700,000, which was paid upon execution of the Fifth Amendment; (iv) eliminated the Company’s limited guaranty of repayment of the loans outstanding by Palisades XVI; and (v) revises the definition of “Borrowing Base Deficit”, as defined in the Receivables Financing Agreement, to mean the excess, if any, of 105% of the loans outstanding over the borrowing base.

In connection with the Fifth Amendment, on October 26, 2010, the Company entered into the Omnibus Termination Agreement (the “Termination Agreement”). The limited recourse subordinated guaranty, discussed under the Fourth Amendment, was eliminated upon signing the Termination Agreement.

The aggregate minimum repayment obligations required under the Fifth Amendment, including interest and principal for fiscal years ending September 30, 2013 (three months ending) and 2014, is $2.3 million and $52.0 million, respectively.

On June 30, 2013 and September 30, 2012, the outstanding balance on this loan was approximately $54.3 million and $61.5 million, respectively. The applicable interest rate at June 30, 2013 and September 30, 2012 was 3.69% and 3.73%, respectively. The average interest rate of the Receivable Financing Agreement was 3.71% for the nine month period ended June 30, 2013 as compared to a 3.76% rate for the fiscal year ended September 30, 2012.

The Company’s average debt obligation for the nine month period ended June 30, 2013 was approximately $57.7 million as compared to a $66.8 million average debt obligation for the fiscal year ended September 30, 2012. The average interest rate for the three month period ended June 30, 2013 was 3.70%.

On August 7, 2013, the Company entered into a Settlement Agreement with BMO as an Amendment to the Receivables Financing Agreement. See Note 16, Subsequent Event, for further information.

Senior Secured Discretionary Credit Facility

On December 30, 2011, the Company and certain of its subsidiaries obtained a $20,000,000 Senior Secured Discretionary Credit Facility (the“Credit Facility”) from Bank Leumi pursuant to a Loan Agreement (the “Loan Agreement”) between certain of the Company’s subsidiaries and Bank Leumi. Under the Loan Agreement, certain subsidiaries issued a Revolving Note (the “Note”) to Bank Leumi in the principal amount of up to $20,000,000. Any outstanding balance under the Credit Facility accrues interest at an annual rate equal to the Prime Rate plus 50 basis points. The Credit Facility was not utilized and expired on February 23, 2013.

17

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 8: Commitments and Contingencies

Employment Agreements

In January 2007, the Company entered into an employment agreement (the “Employment Agreement”) with Gary Stern, its Chairman, President and Chief Executive Officer, which expired on December 31, 2009. Mr. Stern is continuing in his current roles at the discretion of the Board of Directors until a new agreement is signed.

Leases

The Company leases its facilities in Englewood Cliffs, New Jersey, Houston, Texas and New York, New York. Please refer to our consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012, as filed with the SEC, for additional information.

Litigation

In the ordinary course of its business, the Company is involved in numerous legal proceedings. The Company regularly initiates collection lawsuits against consumers, using its network of third party law firms. In addition, consumers occasionally initiate litigation against the Company, alleging that the Company has violated a federal or state law in the process of collecting their account. The Company does not believe that these matters are material to its business and financial condition. The Company is not involved in any material litigation in which it is a defendant.

18

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9: Income Recognition and Impairments

Income Recognition

The Company accounts for its investment in consumer receivables acquired for liquidation using the interest method under the guidance of ASC 310. In ASC 310 static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision.

Once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller). ASC 310 requires that the excess of the contractual cash flows over expected cash flows not be recognized as an adjustment of revenue or expense or on the balance sheet. ASC 310 initially freezes the IRR, estimated when the accounts receivable are purchased, as the basis for subsequent impairment testing. Significant increases in actual, or expected future cash flows may be recognized prospectively through an upward adjustment of the IRR over a portfolio’s remaining life. Any increase to the IRR then becomes the new benchmark for impairment testing. Under ASC 310, rather than lowering the estimated IRR if the collection estimates are not received or projected to be received, the carrying value of a pool would be written down to maintain the then current IRR.

Finance income is recognized on cost recovery portfolios after the carrying value has been fully recovered through collections or amounts written down.

The Company accounts for its investment in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse.

When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

The funding of BPCM matrimonial actions is on a non-recourse basis. BPCM revenues are recognized under the cost recovery method.

Impairments

The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. Increases in expected cash flows are recognized prospectively through an adjustment of the IRR while decreases in expected cash flows are recognized as impairments. ASC 310 makes it more likely that impairment losses and accretable yield adjustments for portfolios’ performances which exceed original collection projections will be recorded, as all downward revisions in collection estimates will result in impairment charges, given the requirement that the IRR of the affected pool be held constant. An impairment of $12.3 million and $10.1 million was recorded during the nine and three month periods ended June 30, 2013. An impairment of $733,000 and $122,000 was recorded during the same prior year periods. The impairment recorded in the third quarter of fiscal 2013 was related to the Great Seneca portfolio as revised forecasts deteriorated during the current quarter. Finance income is not recognized on cost recovery method portfolios until the cost of the portfolio is fully recovered. Collection projections are performed on both interest method and cost recovery method portfolios. With regard to the cost recovery portfolios, if collection projections indicate the carrying value will not be recovered, a write down in value is required.

19

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9: Income Recognition and Impairments

Impairments (continued)

The Company’s analysis of the timing and amount of cash flows to be generated by our portfolio purchases are based on the following attributes:

• the type of receivable, the location of the debtor and the number of collection agencies previously attempting to collect the receivables in the portfolio. The Company has found that there are better states to try to collect receivables and it factors in both better and worse states when establishing its initial cash flow expectations;

• the average balance of the receivables influences the Company’s analysis in that lower average balance portfolios tend to be more collectible in the short-term and higher average balance portfolios are more appropriate for our lawsuit strategy and thus yield better results over the longer term. As the Company has significant experience with both types of balances, it is able to factor these variables into its initial expected cash flows;

• the age of the receivables, the number of days since charge-off, any payments since charge-off, and the credit guidelines of the credit originator also represent factors taken into consideration in our estimation process. For example, older receivables might be more difficult and/or require more time and effort to collect;

• past history and performance of similar assets acquired. As the Company purchases portfolios of like assets, it accumulates a significant historical database on the tendencies of debtor repayments and factors this into its initial expected cash flows;

• the Company’s ability to analyze accounts and resell accounts that meet its criteria;

• jobs or property of the debtors found within portfolios. With the Company’s business model, this is of particular importance. Debtors with jobs or property are more likely to repay their obligation through the lawsuit strategy and, conversely, debtors without jobs or property are less likely to repay their obligation. The Company believes that debtors with jobs or property are more likely to repay because courts have mandated the debtor must pay the debt. Ultimately, the debtor will pay to clear title or release a lien. The Company also believes that these debtors generally might take longer to repay and that is factored into its initial expected cash flows; and

• credit standards of issuer.

The Company acquires accounts that have experienced deterioration of credit quality between origination and the date of its acquisition of the accounts. The amount paid for a portfolio of accounts reflects the Company’s determination that it is probable that the Company will be unable to collect all amounts due according to the portfolio of accounts’ contractual terms. The Company considers the expected payments and estimates the amount and timing of undiscounted expected principal, interest and other cash flows for each acquired portfolio, coupled with expected cash flows from accounts available for sale. The excess of this amount over the cost of the portfolio, representing the excess of the accounts’ cash flows expected to be collected over the amount paid, is accreted into income recognized on finance receivables, and accounted for on the interest method over the expected remaining life of the portfolio.

The Company believes it has extensive experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying debtors. The Company acquires these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid, so that the Company believes that its estimated cash flow offers it an adequate return on its acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, the Company has the added benefit of soliciting its third party servicers for their input with respect to liquidation rates and, at times, incorporates such input into the estimates that the Company uses for its expected cash flows.

As a result of the challenging economic environment and the impact it has had on the collections, for portfolio purchases acquired since the beginning of fiscal year 2009, the Company has extended its time frame of the expectation of recovering 100% of the invested capital to within a 24-29 month period from an 18-28 month period, and the expectation of recovering 130-140% of invested capital to a period of 7 years, an increase from the previous 5-year expectation. The medical accounts are accounted for using the cost recovery method. The Company routinely monitors these expectations against the actual cash flows and, in the event the cash flows are below its expectations and it believes that there are no reasons relating to mere timing differences or explainable delays (such as can occur, particularly when the court system is involved) for the reduced collections, an impairment would be recorded as a provision for credit losses. Conversely, in the event the cash flows are in excess of its expectations and the reason is due to timing, the Company would defer the “excess” collection as deferred revenue.

20

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9: Income Recognition and Impairments

Commissions and Fees

Commissions and fees are the contractual commissions earned by third party collection agencies and attorneys, and direct costs associated with the collection effort; generally court costs. The Company expects to continue to purchase portfolios and utilize third party collection agencies and attorney networks.

Note 10: Income Taxes

Deferred federal and state taxes principally arise from (i) recognition of finance income collected for tax purposes, but not yet recognized for financial reporting; (ii) provision for impairments/credit losses; and (iii) stock based compensation expense for stock option grants and restricted stock awards recorded in the statement of income for which no cash distribution has been made. Other components consist of state net operating loss (“NOL”) carry-forwards. The provision for income tax expense for the three month periods ended June 30, 2013 and 2012, respectively, reflects income tax (benefit) expense at an effective rate of (40.9)% and 40.3%. The provision for income tax expense for the nine month periods ended June 30, 2013 and 2012, respectively, reflects income tax expense at an effective rate of 40.5 % and 40.3%.

The corporate federal income tax returns of the Company for 2009, 2010, 2011 and 2012 are subject to examination by the IRS, generally for three years after they are filed. The state income tax returns and other state filings of the Company are subject to examination by the state taxing authorities, for various periods, generally up to four years after they are filed.

In April 2010, the Company received notification from the IRS that the Company’s 2008, 2009 and 2010 federal income tax returns would be audited. This audit is currently in progress.

Note 11: Net Income (Loss) per Share Attributable to Asta Funding, Inc.

Basic per share data is determined by dividing net income by the weighted average shares outstanding during the period. Diluted per share data is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. With respect to the assumed proceeds from the exercise of dilutive options, the treasury stock method is calculated using the average market price for the period.

The following table presents the computation of basic and diluted per share data for the nine and three months ended June 30, 2013 and 2012:

	Nine Months Ended June 30,
	2013						2012
	Net Income		Weighted Average Shares		Per Share Amount		Net Income		Weighted Average Shares		Per Share Amount
Basic	$	733,000		12,946,521	$	0.06	$	8,485,000		14,440,224	$	0.59
Effect of Dilutive Stock		—		271,382		—		—		243,417		(0.01	)
Diluted	$	733,000		13,217,903	$	0.06	$	8,485,000		14,683,641	$	0.58

21

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11: Net Income (Loss) per Share Attributable to Asta Funding, Inc. (continued)

At June 30, 2013, options to purchase 575,669 shares at a weighted average exercise price of $8.07 were not included in the diluted earnings per share calculation for the nine month period ended June 30, 2013 as they were anti-dilutive.

At June 30, 2012, options to purchase 1,351,492 shares at a weighted average exercise price of $11.82 were not included in the diluted earnings per share calculation for the nine month period ended June 30, 2012 as they were anti-dilutive.

	Three Months Ended June 30,
	2013								2012
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Basic	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,170,575	$	0.22
Effect of Dilutive Stock		—			—		—			—		258,468		(0.01	)
Diluted	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,429,043	$	0.21

At June 30, 2013, options to purchase 554,890 shares at a weighted average exercise price of $9.26 were not included in the diluted earnings per share calculation for the three month period ended June 30, 2013 as they were anti-dilutive.

At June 30, 2012, options to purchase 1,283,875 shares at a weighted average exercise price of $12.02 were not included in the diluted earnings per share calculation for the three month period ended June 30, 2012 as they were anti-dilutive.

Note 12: Stock Based Compensation

The Company accounts for stock-based employee compensation under ASC 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires that compensation expense associated with stock options and other stock based awards be recognized in the statement of income, rather than a disclosure in the notes to the Company’s consolidated financial statements.

In June 2013, through a previous action of the Compensation Committee of the Board of Directors of the Company (“Compensation Committee”) authorizing the Chief Executive Officer of the Company the discretion to grant stock option awards to non-officer employees, the Chief Executive Officer awarded 50,000 stock options to non-officer employees. The exercise price of these options, issued on June 13, 2013, was equal to the market price on that date. The options vest in three equal installments, accounted for as one graded vesting award, starting on the first anniversary of the grant. The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.10	%
Expected term (years)	6.2
Expected volatility	99.7	%
Dividend yield	0.92	%

In December 2012, the Compensation Committee granted 160,000 stock options, of which 65,000 options were awarded to three officers of the Company and 20,000 options were awarded to an employee of the Company. The remaining 75,000 shares were issued to six non-employee directors of the Company. The exercise price of these options, issued on December 18, was equal to the market price on that date. The options vest in three equal installments, accounted for as one graded vesting award, starting on the first anniversary of the grant. The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.16	%
Expected term (years)	6.0
Expected volatility	101.0	%
Dividend yield	1.67	%

22

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 12: Stock Based Compensation (continued)

In addition, the Company granted 102,321 restricted shares to the Chief Executive Officer of the Company. The shares vest in three equal installments, starting on the first anniversary of the grant.

Note 13: Stock Option Plans

2012 Stock Option and Performance Award Compensation Plan

On February 7, 2012, the Board of Directors adopted the Company’s 2012 Stock Option and Performance Award Compensation Plan (the “2012 Plan”), which was approved by the stockholders of the Company on March 21, 2012. The 2012 Plan replaces the Equity Compensation Plan (as defined below).

The 2012 Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted and unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

The Company authorized 2,000,000 shares of Common Stock for issuance under the 2012 Plan. In December 2012, the Company granted options to purchase shares of the Company and an award of restricted stock totaling 262,321 shares. Additionally, the Company granted options to purchase 50,000 shares of the Company to non-executive employees in June 2013, leaving 1,687,679 shares available as of June 30, 2013. As of June 30, 2013, approximately 58 of the Company’s employees were eligible to participate in the 2012 Plan.

Equity Compensation Plan

On December 1, 2005, the Board of Directors adopted the Company’s Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on March 1, 2006. The Equity Compensation Plan was adopted to supplement the Company’s existing 2002 Stock Option Plan (as defined below).

In addition to permitting the grant of stock options as permitted under the 2002 Stock Option Plan, the Equity Compensation Plan allowed the Company flexibility with respect to equity awards by also providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights.

The Company authorized 1,000,000 shares of Common Stock for issuance under the Equity Compensation Plan. As of March 21, 2012, no more options could be issued under this plan.

2002 Stock Option Plan

On March 5, 2002, the Board of Directors adopted the Company’s 2002 Stock Option Plan (the “2002 Plan”), which plan was approved by the Company’s stockholders on May 1, 2002. The 2002 Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company.

The 2002 Plan authorized the granting of incentive stock options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or not employees) and consultants of the Company.

The Company authorized 1,000,000 shares of Common Stock for issuance under the 2002 Plan. As of March 5, 2012, no more options could be issued under this plan.

1995 Stock Option Plan

In 1995, the Board of Directors adopted the Company’s 1995 Stock Option Plan (the “1995 Plan”), which expired on September 14, 2005. The Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company.

The Company authorized 1,840,000 shares of Common Stock for issuance under the 1995 Plan. As of September 14, 2005, no more awards could be issued under this plan.

23

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 13: Stock Option Plans (continued)

The following table summarizes stock option transactions under the plans:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,499,471		$	11.27		1,294,271		$	11.41
Options granted		210,000			9.36		360,000			7.87
Options exercised		(29,500	)		3.51		(19,333	)		3.15
Options forfeited		—			—		(8,300	)		6.02
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,655,871		$	11.12		1,649,538		$	10.64
Options granted		50,000			8.69		—			—
Options exercised		(25,900	)		3.06		(16,000	)		2.95
Options forfeited		—			—		(6,900	)		6.05
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00

The Company recognized $1,307,000 and $532,000 of compensation expense related to stock options during the nine month and three month periods ended June 30, 2013, respectively. Included in stock compensation expense in the nine and three month periods ended June 30, 2013 is approximately $161,000 for non-vested options cancelled during the third quarter of fiscal year 2013. The option awards were not replaced. The Company recognized $1,117,000 and $416,000 of compensation expense related to stock options during the nine month and three month periods ended June 30, 2012, respectively. As of June 30, 2013, there was $2,378,000 of unrecognized compensation expense related to stock option awards. The weighted average remaining period over which such costs are expected to be recognized is 2.0 years. The intrinsic value of the outstanding and exercisable options as of June 30, 2013 was approximately $810,000 and $573,000, respectively. The intrinsic value of the stock options exercised during the nine and three month periods ended June 30, 2013 was approximately $172,000 and $161,000, respectively. The fair value of the stock options exercised during the nine and three month periods ended June 30, 2013 was approximately $276,000 and $241,000, respectively. The weighted average remaining contractual life of exercisable options is 4.1 years. The fair value of the stock options that vested during the nine and three months ended June 30, 2013 was approximately $1,259,000 and $144,000, respectively.

24

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 13: Stock Option Plans (continued)

The following table summarizes information outstanding options under the plans as of June 30, 2013:

	Options Outstanding						Options Exercisable
Range of Exercise Price	Number Outstanding		Weighted Average Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$2.8751 – $5.7500		25,800		5.9	$	2.95		25,800	$	2.95
$5.7501 – $8.6250		790,900		7.7		7.81		482,966		7.77
$8.6251 – $14.3750		260,000		9.3		9.28		50,000		11.50
$14.3751 – $17.2500		198,611		0.4		14.88		198,611		14.88
$17.2501 – $20.1250		339,660		1.3		18.23		339,660		18.23
$25.8751 – $28.7500		15,000		3.5		28.75		15,000		28.75
		1,629,971		5.6	$	11.27		1,112,037	$	12.57

The following table summarizes information about restricted stock transactions:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		10,922		$	7.63		21,843		$	7.63
Awards granted		102,321			9.57		—			—
Vested		(10,922	)		7.63		(10,921	)		7.63
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		102,321		$	9.57		10,922		$	7.63
Awards granted		—			—		—			—
Vested		—			—		—			—
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63

25

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 13: Stock Option Plans (continued)

The Company recognized $191,000 and $81,000 of compensation expense related to the restricted stock awards during the nine and three month periods ended June 30, 2013, respectively. The Company recognized $64,000 and $21,000 of compensation expense related to restricted stock awards during the nine and three month periods ended June 30, 2012, respectively. As of June 30, 2013, there was $805,000 of unrecognized compensation cost related to unvested restricted stock. The weighted average remaining period over which such costs are recognized is 2.5 years.

Note 14: Stockholders’ Equity

In December 2012, the Board of Directors of the Company approved the payment of a special accelerated annual dividend of $0.08 per share to shareholders of record on December 24, 2012. The aggregate dividend of $1,030,000 was paid on December 28, 2012.

On March 9, 2012, the Company adopted a Rule 10b5-1 Plan in conjunction with its share repurchase program. The Board of Directors approved the repurchase of up to $20 million of the Company’s common stock, which was effective through March 11, 2013. The Company purchased approximately 885,000 shares at an aggregate purchase price of approximately $7,948,000 under the plan. Additionally, in June 2012, the Company purchased 1.0 million shares of its common stock for $9.4 million in a privately negotiated transaction outside of the Rule 10b5-1 Plan.

As of June 30, 2013, stockholders’ equity includes an amount for other comprehensive loss of $697,000, which reflects unrealized losses in available-for-sale securities. In addition, $207,000 related to the non-controlling interest in Pegasus Funding, LLC has been included in stockholders’ equity.

Note 15: Fair Value of Financial Instruments

Disclosures about Fair Value of Financial Instruments

FASB ASC 825, Financial Instruments, (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

The estimated fair value of the Company’s financial instruments is summarized as follows:

	June 30, 2013				September 30, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Available-for-sale investments (Level 1)	$	58,336,000	$	58,336,000	$	58,712,000	$	58,712,000
Certificates of deposit (Level 2)		8,764,000		8,764,000		42,682,000		42,682,000
Consumer receivables acquired for liquidation (Level 3)		62,594,000		82,887,000		86,887,000		100,706,000
Financial liabilities
Non-Recourse Debt (Level 2)		54,250,000		28,000,000		61,463,000		61,463,000

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments:

26

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 15: Fair Value of Financial Measurements and Disclosures (continued)

Disclosures about Fair Value of Financial Instruments (continued)

Certificates of deposit — The carrying amount approximates fair value due to the short-term nature of the deposits.

Available-for-sale investments – The available-for-sale securities consist of mutual funds that are valued based on quoted prices in active markets.

Consumer receivables acquired for liquidation – The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of collections for consumer receivables based on variables fully described in Note 4: Consumer Receivables Acquired for Liquidation. These cash flows are discounted to determine the fair value.

Non-Recourse Debt – Carries a variable rate. The fair value has been determined as a result of the Settlement Agreement discussed in Note 16.

Fair Value Hierarchy

The Company recorded its available-for-sale investments at estimated fair value on a recurring basis. The accompanying consolidated financial statements include estimated fair value information regarding its available-for sale investments as of March 31, 2013, as required by FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs, when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement.

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are not active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3- Unobservable inputs that are supported by little or no market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.

The Company’s available-for-sale investments are classified as Level 1 financial instruments based on the classifications described above. The Company did not have any transfers into (out of) Level 1 investments during the periods June 30, 2013 and September 30, 2012. The Company had no Level 2 or Level 3 available-for-sale investments during the periods June 30, 2013 and September 30, 2012.

Note 16: Subsequent Event

On August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with BMO as an amendment to the Receivables Financing Agreement. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next $15 million of collections from the Portfolio Purchase, less certain credits for payments made prior to the consummation of the Settlement Agreement, the Company is entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO will have the right to receive 30% of future net collections. Palisades XVI was in technical violation of the borrowing base covenant at June 30, 2013. The covenant was eliminated entirely from the Settlement Agreement.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Caution Regarding Forward Looking Statements

This report contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” or “will.” These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward–looking statements. For us, particular uncertainties that might cause our actual results to be materially different than those expressed in our forward-looking statements include: our ability purchase defaulted consumer receivables at appropriate prices, changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables, our ability to employ and retain qualified employees, changes in the credit or capital markets, changes in interest rates, deterioration in economic conditions, negative press on the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, potential regulation or limitation of interest rates and other fees advanced by Pegasus under federal and/or state regulation, a change in statutory or case law which limits or restricts the ability of Pegasus to charge or collect fees and interest at anticipated levels, plaintiff’s being unsuccessful in whole or in part in the litigation upon which our funds are provided, the continued services of the senior management of Pegasus to source and analyze cases in accordance with the underwriting guidelines of Pegasus, and such other factors that may be identified from time to time in our Securities and Exchange Commission (“SEC”) filings and other public announcements, including those set forth under the caption “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended September 30, 2012. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Readers are cautioned not to place undue reliance on our forward-looking statements, as they speak only as of the date made. Except as required by law, we assume no duty to update or revise our forward-looking statements.

Overview

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), Pegasus Funding, LLC (“Pegasus”) and other subsidiaries, not all wholly owned, and not considered material (the “Company,” “we” or “us”), is primarily engaged in the business of acquiring, managing, servicing and recovering on portfolios of consumer receivables. These portfolios generally consist of one or more of the following types of consumer receivables:

• charged-off receivables — accounts that have been written-off by the originators and may have been previously serviced by collection agencies;

• semi-performing receivables — accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators; and

• performing receivables — accounts where the debtor is making regular monthly payments that may or may not have been delinquent in the past.

We acquire these consumer receivable portfolios at a significant discount to the amount actually owed by the borrowers. We acquire these portfolios after a qualitative and quantitative analysis of the underlying receivables and calculate the purchase price so that our estimated cash flow offers us an adequate return on our acquisition costs and servicing expenses. After purchasing a portfolio, we actively monitor its performance and review and adjust our collection and servicing strategies accordingly.

We purchase receivables from credit grantors and others through (i) privately negotiated direct sales and (ii) auctions in which sellers of receivables seek bids from several pre-qualified debt purchasers. We pursue new acquisitions of consumer receivable portfolios on an ongoing basis through:

• our relationships with industry participants, collection agencies, investors and our financing sources;

• brokers who specialize in the sale of consumer receivable portfolios; and

• other sources.

28

Personal Injury Litigation Funding Business

We entered into a joint venture with Pegasus Legal Funding, LLC (“PLF”), pursuant to which we purchase interests in personal injury claims from claimants who are a party to personal injury litigation with the expectation of a settlement in the future. Through the joint venture, we advance, to each personal injury claimant, funds on a non-recourse basis, at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by us in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. In 2013, we have committed to fund $20,350,000 to Pegasus Funding.

Matrimonial Claims

On May 18, 2012, we formed BP Case Management, LLC (“BPCM”), a joint venture with a California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”). BPCM provides non-recourse funding to a spouse in a matrimonial action.

Critical Accounting Policies

We account for our investments in consumer receivable portfolios, using either:

• the interest method; or

• the cost recovery method.

As we believe our liquidating experience in certain asset classes such as distressed credit card receivables, telecom receivables, consumer loan receivables and mixed consumer receivables has matured, we use the interest method when we believe we can reasonably estimate the timing of the cash flows. In those situations where we diversify our acquisitions into other asset classes and we do not possess the same expertise, or we cannot reasonably estimate the timing of the cash flows, we utilize the cost recovery method of accounting for those portfolios of receivables.

We account for our investment in finance receivables using the interest method under the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 310, Receivables — Loans and Debt Securities Acquired with Deteriorating Credit Quality, (“ASC 310”). Static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. We currently consider for aggregation portfolios of accounts, purchased within the same fiscal quarter, that generally have the following characteristics:

• same issuer/originator;

• same underlying credit quality;

• similar geographic distribution of the accounts;

• similar age of the receivable; and

• same type of asset class (credit cards, telecommunications, etc.).

After determining that an investment will yield an adequate return on our acquisition cost after servicing fees, including court costs which are expensed as incurred, we use a variety of qualitative and quantitative factors to determine the estimated cash flows. Included in our analysis for purchasing a portfolio of receivables and determining a reasonable estimate of collections and the timing thereof, the following variables are analyzed and factored into our original estimates:

• the number of collection agencies previously attempting to collect the receivables in the portfolio;

• the average balance of the receivables;

• the age of the receivables (as older receivables might be more difficult to collect or might be less cost effective);

• past history of performance of similar assets — as we purchase portfolios of similar assets, we believe we have built significant history on how these receivables will liquidate and factor this into our initial expected cash flows;

29

• number of months since charge-off;

• payments made since charge-off;

• the credit originator and their credit guidelines;

• the locations of the debtors, as there are better states to attempt to collect in and, ultimately, we have better predictability of the liquidations and the expected cash flows. Conversely, there are also states where the liquidation rates are not as good and that is factored into our cash flow analysis;

• financial wherewithal of the seller;

• jobs or property of the debtors found within portfolios-with our business model, this is of particular importance as debtors with jobs or property are more likely to repay their obligation and, conversely, debtors without jobs or property are less likely to repay their obligation; and

• the ability to obtain customer statements from the original issuer.

We will obtain and utilize, as appropriate, input including, but not limited to, monthly collection projections and liquidation rates, from our third party collection agencies and attorneys, as further evidentiary matter, to assist us in developing collection strategies and in modeling the expected cash flows for a given portfolio.

We acquire accounts that have experienced deterioration of credit quality between origination and the date of our acquisition of the accounts. The amount paid for a portfolio of accounts reflects our determination that it is probable we will be unable to collect all amounts due according to the portfolio of accounts’ contractual terms. We consider the expected payments and estimate the amount and timing of undiscounted expected principal, interest and other cash flows for each acquired portfolio coupled with expected cash flows from accounts available for sale. The excess of this amount over the cost of the portfolio, representing the excess of the accounts’ cash flows expected to be collected over the amount paid, is accreted into income recognized on finance receivables over the expected remaining life of the portfolio.

We believe we have significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying debtors. We acquire these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that we believe our estimated cash flow offers us an adequate return on our costs, including servicing expenses. Additionally, when considering purchases of accounts, or portfolios from issuers from whom we have little or limited experience, we have the added benefit of soliciting our third party collection agencies and attorneys for their input on liquidation rates and, at times, incorporate such input into the price we offer for a given portfolio and the estimates we use for our expected cash flows.

As a result of the recent and current challenging economic environment and the impact it has had on the collections, for the non medical account portfolio purchases acquired since the beginning of fiscal year 2009, we have extended our time frame of the expectation of recovering 100% of our invested capital to within a 24-29 month period from an 18-28 month period, and the expectation of recovering 130-140% of invested capital to a period of seven years, which is an increase from the previous five year expectation. The medical accounts are accounted for using the cost recovery method. We routinely monitor these expectations against the actual cash flows and, in the event the cash flows are below our expectations and we believe there are no reasons relating to mere timing differences or explainable delays (such as can occur particularly when the court system is involved) for the reduced collections, an impairment would be recorded as a provision for credit losses. Conversely, in the event the cash flows are in excess of our expectations and the reason is due to timing, we would defer the “excess” collection as deferred revenue.

We use the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.

We account for our investment in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse.

When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

The funding of BPCM matrimonial actions is on a non-recourse basis. BPCM revenues are recognized under the cost recovery method.

In the following discussions, most percentages and dollar amounts have been rounded to aid presentation. As a result, all figures are approximations.

30

Results of Operations

The nine-month period ended June 30, 2013, compared to the nine-month period ended June 30, 2012

Finance income. For the nine month period ended June 30, 2013, finance income decreased $4.0 million, or 13.0%, to $26.8 million from $30.8 million for the nine month period ended June 30, 2012. Finance income decreased primarily due to the lower level of portfolio purchases and, as a result, the increased percentage of our portfolio balances are in the later stages of their yield curves. We purchased a portfolio with a face value of approximately $53.5 million at a cost of $3.3 million in the first nine months of fiscal year 2013, compared to $6.0 million in face value of new portfolios at a cost of $2.7 million in the first nine months of fiscal year 2012.

During the first nine months of fiscal year 2013, gross collections decreased 20.4% to $66.4 million from $83.4 million for the nine months ended June 30, 2012, reflecting the lower level of purchases and the age of our portfolios. Commissions and fees associated with gross collections from our third party collection agencies and attorneys decreased $4.9 million, or 16.7%, for the nine months ended June 30, 2013 as compared to the same period in the prior year and averaged 34.7% of collections for the nine months ended June 30, 2013 as compared to 35.0% for the same prior year period. Net collections decreased 22.4% to $42.0 million from $54.2 million for the nine months ended June 30, 2012. Income recognized from fully amortized portfolios (zero based revenue) was $25.8 million for the nine month period ended June 30, 2013 compared to $27.4 million for the nine month period ended June 30, 2012. Included in finance income for the nine month period ended June 30, 2013 is approximately $1.6 million related to $2.0 million of account sales which occurred during the third quarter of fiscal year 2013.

Other income. The following table summarizes other income for the six month periods ended:

	June 30,
	2013			2012
Interest and dividend income	$	1,201,000		$	1,199,000
Personal injury fee income		4,921,000			999,000
Matrimonial fee income		—			165,000
Realized gain (including capital gain)		417,000			251,000
Service fee income		23,000			84,000
Other		(13,000	)		21,000
	$	6,549,000		$	2,719,000

The change in the personal injury fee income component of other income for the nine month period ended June 30, 2013 as compared to the nine month period ended June 30, 2012 is primarily due to the increased level of investment in personal injury cases since the inception of the personal injury business in December 2011. Net investment in personal injury cases increased by $13.7 million, from $18.6 million to $32.3 million during the first nine months of fiscal year 2013, compared to a $13.0 million increase from $0 in the first nine months of fiscal year 2012.

General and administrative expenses. During the nine months ended June 30, 2013, general and administrative expenses increased $1.4 million, or 8.7%, to $17.9 million from $16.5 million for the nine months ended June 30, 2012. The increase in general and administrative expenses is primarily attributable to the inclusion of Pegasus for nine months in the current period as compared to only six months in the same prior year period, as the business began on December 28, 2011. Included in the general and administrative expenses is an increase in the reserve for bad debts consistent with the growth of Pegasus. General and administrative expenses related to the consumer debt portion of our business have decreased $1.9 million or 12.3%, as we have taken actions to increase our reliance on our third party collection network.

Interest expense. During the nine month period ended June 30, 2013, interest expense decreased $0.3 million or 16.4% to $1.6 million from $1.9 million in the same prior year period. The decrease in interest expense is primarily the result of the continued repayment of our non-recourse debt.

Impairments. An impairment of $12.4 million was recorded in the nine month period ended June 30, 2013 as compared to an impairment of $0.7 million recorded during the nine month period ended June 30, 2012. The primary reason for the impairment is the $10.2 million write down of the Great Seneca portfolio as revised forecasts developed during the third quarter of fiscal year 2013 indicated a further deterioration of collections.

Income tax expense. Income tax expense, consisting of federal and state income taxes, was $0.5 million for the nine months ended June 30, 2013, as compared to income tax expense of $5.8 million for the comparable 2012 period.

31

Income attributable to non-controlling interest. The income attributable to non-controlling interest of $176,000 in fiscal year 2013 and $66,000 in fiscal year 2012, related to PLF’s 20% interest in Pegasus.

Net income attributable to Asta Funding, Inc. For the nine months ended June 30, 2013, net income was $0.7 million, as compared to net income of $8.5 million for the nine month period ended June 30, 2012.

The three-month period ended June 30, 2013, compared to the three-month period ended June 30, 2012

Finance income. For the three month period ended June 30, 2013, finance income was $10.0 million as compared to $10.5 million for the three month period ended June 30, 2012, a decrease of $0.5 million. We purchased a portfolio with a face value of approximately $53.5 million at a cost of $3.3 million during the third quarter of fiscal year 2013. There were no portfolio purchases during the third quarter of fiscal year 2012. Included in finance income during the third quarter of fiscal year 2013 was approximately $1.6 million of income from account sales of approximately $2.0 million,

During the third quarter of fiscal year 2013, gross collections decreased 16.4% to $23.4 million from $28.0 million for the three months ended June 30, 2012. Commissions and fees associated with gross collections from our third party collection agencies and attorneys decreased $1.5 million, or 16.1%, for the three months ended June 30, 2013 as compared to the same period in the prior year and averaged 34.2% of collections during the three-month period ended June 30, 2013. Net collections decreased by 16.5% to $15.4 million in the current quarter from $18.5 million for the three months ended June 30, 2012. Income recognized from fully amortized portfolios (zero based revenue) was $9.7 million and $9.6 million for the three months ended June 30, 2013 and 2012, respectively. Included in in the zero based revenue is $1.6 from the account sales during the third quarter of fiscal year 2013.

Other income. The following table summarizes other income for the three month periods ended:

	June 30,
	2013			2012
Interest and dividend income	$	371,000		$	396,000
Personal injury fee income		2,287,000			507,000
Realized gains		17,000			134,000
Service fee income		7,000			30,000
Other		(17,000	)		3,000
	$	2,665,000		$	1,070,000

The change in the personal injury fee income component of other income for the three month period ended June 30, 2013 as compared to the three month period ended June 30, 2012 is primarily due to the increased level of investment in personal injury cases since the inception of the personal injury business in December 2011. Net investment in personal injury cases increased by $4.1 million from $28.2 million to $32.3 million during the three month period ended June 30, 2013, compared to a $5.3 million increase from $7.7 million during the three month period ended June 30, 2012.

General and administrative expenses. During the three-month period ended June 30, 2013, general and administrative expenses increased $0.9 million, or 15.0%, to $6.5 million from $5.7 million for the three months ended June 30, 2012. The increase is primarily related to the growth of Pegasus as the unit has grown significantly over the last year. Included in the general and administrative expenses is an increase in the reserve for bad debts consistent with the growth of Pegasus. General and administrative expenses related to the consumer debt portion of our business have decreased $0.7 million or 14.2%, as we have taken actions to increase our reliance on our third party collection network.

Interest expense. During the three-month period ended June 30, 2013, interest expense was $518,000 compared to $619,000 in the same period in the prior year. The decrease in interest expense is the result of the continued repayment of our non-recourse debt.

Impairments. An impairment of $10.2 million was recorded in the three month period ended June 30, 2013 as compared to an impairment of $122,000 recorded during the three month period ended June 30, 2012. The reason for the impairment is the $10.2 million write down of the Great Seneca portfolio as revised forecasts developed during the third quarter of fiscal year 2013 indicated a further deterioration of collections.

Income tax (benefit) expense. Income tax (benefit) of $1.9 million was recorded for the three month period ended June 30, 2013 as compared to $2.1 million of income tax expense for the three month period ended June 30, 2012.

Income attributable to non-controlling interest. The income attributable to non-controlling interest of $53,000 and $17,000 for the three month periods ended June 30, 2013 and 2012, respectively, related to PLF’s 20% interest in Pegasus.

32

Net (loss) income attributable to Asta Funding, Inc. Net (loss) attributable to Asta Funding, Inc. was $2.7 million for the three month period ended June 30, 2013 as compared to net income attributable to Asta Funding, Inc. of $3.0 million for the three month period ended June 30, 2012.

Liquidity and Capital Resources

Our primary source of cash from operations is collections on the receivable portfolios we have acquired. Our primary uses of cash include our acquisition of consumer receivable portfolios, interest payments, costs involved in the collections of consumer receivables, taxes, dividends, if approved, and repayment of debt. We currently rely on cash provided by operations to fund the acquisition of consumer receivables and general operations of the business.

Receivables Financing Agreement

In March 2007, Palisades XVI entered into a receivables financing agreement (the “Receivables Financing Agreement”) with the Bank of Montreal (“BMO”), as amended in July 2007, December 2007, May 2008, February 2009 and October 2010 in order to finance the Portfolio Purchase. The Portfolio Purchase had a purchase price of $300 million (plus 20% of net payments after Palisades XVI recovers 150% of its purchase price plus cost of funds, which recovery has not yet occurred). Prior to the modifications, discussed below, the debt was full recourse only to Palisades XVI and accrued interest at the rate of approximately 170 basis points over LIBOR. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments to the Receivables Financing Agreement as discussed below.

On October 26, 2010, Palisades XVI entered into the Fifth Amendment to the Receivables Financing Agreement (the “Fifth Amendment”). The effective date of the Fifth Amendment was October 14, 2010. The Fifth Amendment (i) extends the expiration date of the Receivables Financing Agreement to April 14, 2014; (ii) reduces the minimum monthly payment to $750,000; (iii) accelerated our guaranty credit enhancement of $8,700,000, which was paid upon the execution of the Fifth Amendment; (iv) eliminated our limited guaranty of repayment of the loans outstanding by Palisades XVI; and (v) revises the definition of “Borrowing Base Deficit”, as defined in the Receivables Financing Agreement, to mean the excess, if any, of 105% of the loans outstanding over the borrowing base.

In connection with the Fifth Amendment, on October 26, 2010, we entered into the Omnibus Termination Agreement (the “Termination Agreement”). The limited recourse subordinated guaranty discussed under the Fourth Amendment was eliminated upon signing the Termination Agreement.

The aggregate minimum repayment obligations required under the Fifth Amendment, including interest and principal for fiscal years ending September 30, 2013 (three months ending) and 2014, is $2.3 million and $52.0 million, respectively.

On June 30, 2013 and September 30, 2012, the outstanding balance on this loan was approximately $54.3 million and $61.5 million, respectively. The applicable interest rate at June 30, 2013 and September 30, 2012, was 3.69% and 3.73%, respectively. The average interest rate of the Receivable Financing Agreement was 3.71% for the nine-month period ended June 30, 2013 as compared to 3.76% for the fiscal year ended September 30, 2012. We were in compliance with all covenants at June 30, 2013.

33

On August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with BMO as an amendment to the Receivables Financing Agreement. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next $15 million of collections from the Portfolio Purchase, less certain credits for payments made prior to the consummation of the Settlement Agreement, the Company is entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO will have the right to receive 30% of future net collections. Palisades XVI was in technical violation of the borrowing base covenant at June 30, 2013. The covenant was waived and eliminated entirely from the Settlement Agreement.

Senior Secured Discretionary Credit Facility

On December 30, 2011, we and certain of our subsidiaries obtained a $20,000,000 Senior Secured Discretionary Credit Facility (the “Credit Facility”) from Bank Leumi pursuant to a Loan Agreement (the “Loan Agreement”) between certain of our subsidiaries and Bank Leumi. Under the Loan Agreement, certain of our subsidiaries issued a Revolving Note to Bank Leumi in the principal amount of up to $20,000,000. Any outstanding balance under the Credit Facility accrues interest at an annual rate equal to the Prime Rate plus 50 basis points. The Credit Facility was not utilized and expired on February 23, 2013.

Other Investments – Personal Injury Claims

On December 28, 2011, we, through an indirect subsidiary, APH, entered into a joint venture (the “Venture”) with PLF. The Venture, through Pegasus, purchases interests in personal injury claims from claimants who are a party to a personal injury litigation, with the expectation of a settlement in the future. The personal injury claims are purchased by Pegasus. Pegasus advances to each claimant funds on a non-recourse basis at an agreed upon interest rate in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case.

When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

In connection with the Venture, pursuant to a Revolving Credit Agreement, Security Agreement and Secured Revolving Credit Note, Fund Pegasus, our indirect wholly-owned subsidiary, agreed to fund Pegasus an aggregate of up to $109 million over a five (5) year period, payable in one or more installments, consisting of up to $20,000,000 to purchase claims and up to $1.8 million to cover Pegasus’ overhead expenses (which amount includes a 4% management fee payable by Pegasus to PLF). Actual overhead expenses have been funded at the higher of 12% of funds invested or $210,000 per month. Overhead expenses are repaid to the Company before any profit from cases is distributed. The amounts due shall accrue interest at the annual rate of 1%, which interest shall be paid monthly to Fund Pegasus by Pegasus.

Other Investments – Matrimonial Claims

On May 18, 2012, we formed BPCM, a joint venture with California-based BP Divorce Funding. BPCM provides non-recourse funding to a spouse in a matrimonial action. We provided a $1 million revolving line of credit to partially fund BP Divorce Funding’s operations, with the loan bearing interest at the prevailing prime rate, with an initial term of 24 months. The revolving line of credit is collateralized by BP Divorce Funding’s profit share in BPCM and other assets.

Cash Flow

Our cash increased $33.3 million, from $4.9 million at September 30, 2012, to $38.2 million at June 30, 2013.

Net cash provided by operating activities was $12.8 million during the nine month period ended June 30, 2013, compared to $15.7 million for the nine months ended June 30, 2012. The decrease is primarily attributable to a decrease in other assets in the current period. Net cash provided by investing activity was $30.4 million during the nine months ended June 30, 2013 compared to net cash used in investing activities of $54.6 million for the nine months ended June 30, 2012, primarily a reflection of an increase in proceeds from maturities of certificates of deposit and sales of available-for-sale securities in the current fiscal year combined with a decrease in purchases of both available-for-sale securities and certificates of deposit from the prior year, partially offset by a decrease in principal collected on consumer receivables acquired for liquidation. Net cash used in financing activities decreased from $21.4 million for the nine months ended June 30, 2012 to $10.0 million for the same period in the current year. This decrease is primarily a reflection of the $9.4 million privately negotiated transaction, whereby we repurchased 1.0 million shares of our common stock in June 2012.

34

Our cash requirements have been and will continue to be significant and have, in the past, depended on external financing to acquire consumer receivables and operate the business. Significant requirements include repayments under our debt facilities, purchase of consumer receivable portfolios, interest payments, costs involved in the collections of consumer receivables, and taxes. In addition, dividends are paid, if approved by the Board of Directors. Historically, acquisitions have been financed through cash flows from operating activities and a credit facility. In recent periods we have utilized cash flow from operations to finance acquisitions. We believe we will be less dependent on a credit facility in the short-term as our cash flow from operations will be sufficient to make investments and operate the business. However, as the collection environment remains challenging, we may seek additional financing.

Our business model affords us the ability to sell accounts on an opportunistic basis. In the third quarter of fiscal year 2013, we sold approximately one million accounts for approximately $2.0 million. Included in finance income is approximately $1.6 million, of which $1.3 million was derived from fully amortized portfolios. The following tables summarize the changes in the balance sheet of the investment in consumer receivables acquired for liquidation during the following periods:

	For the Nine Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	12,326,000		$	74,561,000		$	86,887,000
Acquisition of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collection of consumer receivables acquired for liquidation		(26,901,000	)		(13,113,000	)		(40,014,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(987,000	)		(1,037,000	)		(2,024,000	)
Impairment		(2,203,000	)		(10,148,000	)		(12,351,000	)
Finance income recognized (1)		23,531,000			3,225,000			26,756,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		84.4	%		22.8	%		63.6	%

(1) Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized potfolios is approximately $1.6 million from account sales which occurred in the third quarter.

	For the Nine Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	31,193,000		$	84,002,000		$	115,195,000
Acquisitions of receivable portfolios		1,278,000			1,397,000			2,675,000
Net cash collections from collection of consumer receivables acquired for liquidation		(38,550,000	)		(15,519,000	)		(54,069,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(89,000	)		—			(89,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(733,000	)		—			(733,000	)
Finance income recognized (1)		28,641,000			2,120,000			30,761,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		74.1	%		13.7	%		56.8	%

(1) Includes approximately $27.4 million derived from fully amortized portfolios.

35

	For the Three Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	6,813,000		$	68,011,000		$	74,824,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collections of consumer receivables acquired for liquidation		(8,611,000	)		(4,807,000	)		(13,418,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(970,000	)		(1,037,000	)		(2,007,000	)
Impairment		—			(10,148,000	)		(10,148,000	)
Finance income recognized (1)		8,534,000			1,469,000			10,003,000
Balance, end of period	$	9,106,000			($53,488,000	)	$	62,594,000
Finance income as a percentage of collections		89.1	%		25.1	%		64.8	%

(1) Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

	For the Three Months Ended June 30, 2012
				Cost
	Interest			Recovery
	Method			Method			Total
Balance, beginning of period	$	24,897,000		$	76,939,000		$	101,836,000
Net cash collections from collections of consumer receivables acquired for liquidation		(12,672,000	)		(5,792,000	)		(18,464,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(11,000	)		—			(11,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairments		(122,000	)		—			(122,000	)
Finance income recognized (1)		9,648,000			853,000			10,501,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		76.1	%		14.7	%		56.8	%

(1) Includes approximately $9.6 million derived from fully amortized portfolios.

Off Balance Sheet Arrangements

As of June 30, 2013, we did not have any relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

36

Additional Supplementary Information:

We do not anticipate collecting the majority of the purchased principal amounts. Accordingly, the difference between the carrying value of the portfolios and the gross receivables is not indicative of future revenues from these accounts acquired for liquidation. Since we purchased these accounts at significant discounts, we anticipate collecting only a small portion of the face amounts. During both the three and nine month period ended June 30, 2013, we purchased approximately $53.5 million of face value receivables at a cost of $3.3 million. During the nine months ended June 30, 2012, we purchased portfolios with a face value of $6.0 million for an aggregate purchase price of $2.7 million.

For additional information regarding our methods of accounting for our investment in finance receivables, the qualitative and quantitative factors we use to determine estimated cash flows, and our performance expectations of our portfolios, see “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” above.

Collections Represented by Account Sales

Period	Collections Represented By Account Sales		Finance Income Earned
Nine months ended June 30, 2013	$	2,024,000	$	1,592,000
Three months ended June 30, 2013	$	2,007,000	$	1,583,000
Nine months ended June 30, 2012	$	88,000	$	35,000
Three months ended June 30, 2012	$	10,000	$	4,000

Portfolio Performance (1)

(Interest method portfolios only)

Purchase Period	Purchase Price (2)		Cash Collections Including Cash Sales (3)		Estimated Remaining Collections (4)		Total Estimated Collections (5)		Total estimated Collections as  a Percentage of Purchase Price
2001	$	65,120,000	$	105,746,000	$	—	$	105,746,000		162	%
2002		36,557,000		48,320,000		—		48,320,000		132	%
2003		115,626,000		223,546,000		—		223,546,000		193	%
2004		103,743,000		193,612,000		3,000		193,615,000		187	%
2005		126,023,000		228,872,000		490,000		229,362,000		182	%
2006		163,392,000		273,739,000		1,422,000		275,161,000		168	%
2007		109,235,000		109,337,000		4,254,000		113,591,000		104	%
2008		26,626,000		52,979,000		7,000		52,986,000		199	%
2009		19,127,000		40,058,000				40,058,000		210	%
2010		7,212,000		22,920,000		—		22,920,000		318	%
2011-2012		—		—		—		—		—
2013		3,340,000		—		4,342,000		4,342,000		130	%

(1) Total collections do not represent full collections of the Company with respect to this or any other year.

(2) Purchase price refers to the cash paid to a seller to acquire a portfolio less the purchase price refunded by a seller due to the return of non-compliant accounts (also defined as put-backs).

(3) Net cash collections include: net collections from our third-party collection agencies and attorneys, net collections from our in-house efforts and collections represented by account sales.

(4) Does not include estimated collections from portfolios that are zero basis.

(5) Total estimated collections refers to the actual net cash collections, including cash sales, plus estimated remaining net collections.

37

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02 “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”. The amendments require an entity to present, either in the income statement or the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required under U.S. Generally Accepted Accounting Principles (“GAAP”) to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety, an entity is required to cross-reference to other disclosures that might provide additional details about the amounts. This ASU was effective for annual and interim periods beginning January 1, 2013. Adoption of the ASU did not have a significant effect on our consolidated financial statements.

In December 2011, the FASB issued ASU No. 2011-12, amended ASC Topic 220 “Comprehensive Income.” The amendments defer certain disclosure requirements regarding reclassifications within ASU No. 2011-05, until the FASB can deliberate further on these requirements. The amendments in this update are effective for the annual period beginning on or after December 15, 2012 and must be applied retrospectively. We chose to early-adopt ASU 2011-12 and implementation of this guidance has not had a material effect on our consolidated financial statements.

38

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to various types of market risk in the normal course of business, including the impact of interest rate changes and changes in corporate tax rates. A material change in these rates could adversely affect our operating results and cash flows. At June 30, 2013, our Receivables Financing Agreement, which is variable debt, had an outstanding balance of $54.3 million. A 25 basis-point increase in interest rates would have increased our interest expense for the nine month period ended June 30, 2013 by approximately $108,000 based on the average debt outstanding during the period. We do not currently invest in derivative financial or commodity instruments.

Item 4. Controls and Procedures

a. Disclosure Controls and Procedures.

As of June 30, 2013, we carried out an evaluation, with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 promulgated under the Securities Exchange Act of 1934, as amended the (“Exchange Act”). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of June 30, 2013 are effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our principal executive officers and our principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

b. Changes in Internal Controls over Financial Reporting.

There have been no significant changes in our internal controls over financial reporting that occurred during our fiscal quarter ended June 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of third party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting their account. We do not believe that these ordinary course matters are material to our business and financial condition. As of the date of this Form 10-Q, we are not involved in any material litigation in which we are a defendant.

Item 1A. Risk factors

There were no material changes in any risk factors previously disclosed on Form 10-K for the fiscal year ended September 30, 2012, as filed with the SEC on January 18, 2013.

40

Item 6. Exhibits

(a) Exhibits

16.1	Letter dated April 15, 2013 addressed to the Securities and Exchange Commission from Grant Thornton, LLP (incorporated by reference to Exhibit 16.1 to the current report on Form 8-K, file with the Commission on April 15, 2013.)
31.1	Certification of the Registrant’s Chief Executive Officer, Gary Stern, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Registrant’s Chief Financial Officer, Robert J. Michel, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Registrant’s Chief Executive Officer, Gary Stern, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Registrant’s Chief Financial Officer, Robert J. Michel, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101. INS	XBRL Instance
101. SCH	XBRL Taxonomy Extension Schema
101. CAL	XBRL Taxonomy Extension Calculation
101. DEF	XBRL Taxonomy Extension Definition
101. LAB	XBRL Taxonomy Extension Labels
101. PRE	XBRL Taxonomy Extension Presentation

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASTA FUNDING, INC. (Registrant)
Date: August 9, 2013	By:	/s/ Gary Stern
		Gary Stern, Chairman, President,
		Chief Executive Officer (Principal Executive Officer)
Date: August 9, 2013	By:	/s/ Robert J. Michel
		Robert J. Michel, Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

42

EXHIBIT INDEX

Exhibit No.	Description
31.1	Certification of the Registrant’s Chief Executive Officer, Gary Stern, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Registrant’s Chief Financial Officer, Robert J. Michel, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Registrant’s Chief Executive Officer, Gary Stern, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Registrant’s Chief Financial Officer, Robert J. Michel, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101. INS	XBRL Instance
101. SCH	XBRL Taxonomy Extension Schema
101. CAL	XBRL Taxonomy Extension Calculation
101. DEF	XBRL Taxonomy Extension Definition
101. LAB	XBRL Taxonomy Extension Labels
101. PRE	XBRL Taxonomy Extension Presentation

43

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Gary Stern, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d — 15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 9, 2013

/s/ Gary Stern

Gary Stern,

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Robert J. Michel, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d — 15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 9, 2013

/s/ Robert J. Michel

Robert J. Michel, Chief Financial Officer

(Principal Financial Officer and

Principal Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Asta Funding, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2013, filed with the Securities and Exchange Commission (the “Report”), I, Gary Stern, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Dated: August 9, 2013

/s/ Gary Stern

Gary Stern

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to Asta Funding, Inc. and will be retained by Asta Funding, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Asta Funding, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2013, filed with the Securities and Exchange Commission (the “Report”), I, Robert J. Michel, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Dated: August 9, 2013

/s/ Robert J. Michel

Robert J. Michel

Chief Financial Officer

(Principal Financial Officer and

Principal Accounting Officer)

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to Asta Funding, Inc. and will be retained by Asta Funding, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Non-Recourse Debt

9 Months Ended

Jun. 30, 2013

Non-Recourse Debt

Note 7: Non-Recourse Debt

Receivables Financing Agreement

In March 2007, Palisades XVI borrowed approximately $227 million under the Receivables Financing Agreement, as amended in July 2007, December 2007, May 2008, February 2009 and October 2010, in order to finance the Portfolio Purchase. The Portfolio Purchase had a purchase price of $300 million (plus 20% of net payments after Palisades XVI recovers 150% of its purchase price plus cost of funds, which recovery has not yet occurred). Prior to the modification, discussed below, the debt was full recourse only to Palisades XVI and accrued interest at the rate of approximately 170 basis points over LIBOR. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments to the Receivables Financing Agreement as discussed below. Proceeds received as a result of the net collections from the Portfolio Purchase are applied to interest and principal of the underlying loan. The Portfolio Purchase is serviced by Palisades Collection LLC, which has engaged unaffiliated subservicers for a majority of the Portfolio Purchase.

Since the inception of the Receivables Financing Agreement, amendments have been signed to revise various terms of the Receivables Financing Agreement. On October 26, 2010, Palisades XVI entered into the Fifth Amendment to the Receivables Financing Agreement (the “Fifth Amendment”). The effective date of the Fifth Amendment was October 14, 2010. The Fifth Amendment (i) extends the expiration date of the Receivables Financing Agreement to April 14, 2014; (ii) reduces the minimum monthly total payment to $750,000; (iii) accelerated the Company’s guaranty credit enhancement of $8,700,000, which was paid upon execution of the Fifth Amendment; (iv) eliminated the Company’s limited guaranty of repayment of the loans outstanding by Palisades XVI; and (v) revises the definition of “Borrowing Base Deficit”, as defined in the Receivables Financing Agreement, to mean the excess, if any, of 105% of the loans outstanding over the borrowing base.

In connection with the Fifth Amendment, on October 26, 2010, the Company entered into the Omnibus Termination Agreement (the “Termination Agreement”). The limited recourse subordinated guaranty, discussed under the Fourth Amendment, was eliminated upon signing the Termination Agreement.

The aggregate minimum repayment obligations required under the Fifth Amendment, including interest and principal for fiscal years ending September 30, 2013 (three months ending) and 2014, is $2.3 million and $52.0 million, respectively.

On June 30, 2013 and September 30, 2012, the outstanding balance on this loan was approximately $54.3 million and $61.5 million, respectively. The applicable interest rate at June 30, 2013 and September 30, 2012 was 3.69% and 3.73%, respectively. The average interest rate of the Receivable Financing Agreement was 3.71% for the nine month period ended June 30, 2013 as compared to a 3.76% rate for the fiscal year ended September 30, 2012.

The Company’s average debt obligation for the nine month period ended June 30, 2013 was approximately $57.7 million as compared to a $66.8 million average debt obligation for the fiscal year ended September 30, 2012. The average interest rate for the three month period ended June 30, 2013 was 3.70%.

On August 7, 2013, the Company entered into a Settlement Agreement with BMO as an Amendment to the Receivables Financing Agreement. See Note 16, Subsequent Event, for further information.

Senior Secured Discretionary Credit Facility

On December 30, 2011, the Company and certain of its subsidiaries obtained a $20,000,000 Senior Secured Discretionary Credit Facility (the“Credit Facility”) from Bank Leumi pursuant to a Loan Agreement (the “Loan Agreement”) between certain of the Company’s subsidiaries and Bank Leumi. Under the Loan Agreement, certain subsidiaries issued a Revolving Note (the “Note”) to Bank Leumi in the principal amount of up to $20,000,000. Any outstanding balance under the Credit Facility accrues interest at an annual rate equal to the Prime Rate plus 50 basis points. The Credit Facility was not utilized and expired on February 23, 2013.

XML

Stock Based Compensation - Additional Information (Detail)	3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012 Installment	Jun. 30, 2013	Jun. 30, 2012	Mar. 31, 2013	Sep. 30, 2012	Mar. 31, 2012	Sep. 30, 2011
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Number of shares utilized	50,000	160,000		210,000	360,000
Number of installment period of stock options vested	3 years	3 years
Stock option awarded	1,629,971		1,626,638	1,629,971	1,626,638	1,655,871	1,499,471	1,649,538	1,294,271
Number of non-employee directors		6
Number of shares vesting installments			3
Non Officer Employees
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Number of shares utilized	50,000
Chief Executive Officer
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Stock option awarded		65,000
Employee
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Stock option awarded		20,000
Non Employee Director
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Stock option awarded		75,000
Restricted stock to Chief Executive Officer
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Stock options issued				102,321

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended				9 Months Ended
	Jun. 30, 2013		Jun. 30, 2012		Jun. 30, 2013		Jun. 30, 2012
Revenues:
Finance income, net	$ 10,003,000	[1]	$ 10,501,000	[2]	$ 26,756,000	[3]	$ 30,761,000	[4]
Other income (includes $17,000 and $134,000 during the three months ended June 30, 2013 and 2012, respectively; and $192,000 and $251,000 during the nine months ended June 30, 2013 and 2012, respectively, of accumulated other comprehensive income reclassifications for unrealized net gains on available for sale securities.)	2,665,000		1,070,000		6,549,000		2,719,000
Total Revenue	12,668,000		11,571,000		33,305,000		33,480,000
Expenses:
General and administrative	6,545,000		5,694,000		17,926,000		16,492,000
Interest	518,000		619,000		1,621,000		1,939,000
Impairments of consumer receivables acquired for liquidation	10,148,000		122,000		12,351,000		733,000
Total expenses	17,211,000		6,435,000		31,898,000		19,164,000
(Loss) income before income tax	(4,543,000)		5,136,000		1,407,000		14,316,000
Income tax (benefit) expense	(1,859,000)		2,071,000		498,000		5,765,000
Net (loss) income	(2,684,000)		3,065,000		909,000		8,551,000
Less: net income attributable to non-controlling interest	53,000		17,000		176,000		66,000
Net (loss) income attributable to Asta Funding, Inc.	$ (2,737,000)		$ 3,048,000		$ 733,000		$ 8,485,000
Net (loss) income per share attributable to Asta Funding, Inc.:
Basic	$ (0.21)		$ 0.22		$ 0.06		$ 0.59
Diluted	$ (0.21)		$ 0.21		$ 0.06		$ 0.58
Weighted average number of common shares outstanding:
Basic	12,954,455		14,170,575		12,946,521		14,440,224
Diluted	12,954,455		14,429,043		13,217,903		14,683,641

[1] Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

[2] Includes approximately $9.6 million derived from fully amortized portfolios.

[3] Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales which occurred in the third quarter.

[4] Includes approximately $27.4 million derived from fully amortized portfolios.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 909,000	$ 8,551,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	450,000	410,000
Deferred income taxes	85,000	1,375,000
Impairments of consumer receivables acquired for liquidation	12,351,000	733,000
Stock based compensation	1,498,000	1,181,000
Gain on sale of available-for-sale securities	(192,000)	(251,000)
Changes in:
Other assets	(2,369,000)	(370,000)
Due from third party collection agencies and attorneys	802,000	53,000
Prepaid and income taxes receivable	382,000	4,390,000
Other liabilities	(1,104,000)	(392,000)
Net cash provided by operating activities	12,812,000	15,680,000
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation	(3,340,000)	(2,675,000)
Principal collected on consumer receivables acquired for liquidation	14,850,000	23,344,000
Principal collected on consumer receivable accounts represented by account sales	432,000	53,000
Purchase of available-for-sale securities	(29,907,000)	(57,128,000)
Proceeds from sale of available-for-sale securities	28,918,000	13,405,000
Purchase of certificates of deposit		(25,050,000)
Proceeds from maturities of certificates of deposits	33,918,000	6,544,000
Other investments - advances	(22,863,000)	(14,906,000)
Other investments - receipts	9,162,000	1,870,000
Capital expenditures	(725,000)	(63,000)
Net cash provided by (used in) investing activities	30,445,000	(54,606,000)
Cash flows from financing activities:
Proceeds from exercise of options	103,000	61,000
Purchase of treasury stock	(1,579,000)	(13,106,000)
Change in restricted cash	21,000	(199,000)
Dividends paid	(1,290,000)	(875,000)
Repayments of non-recourse debt	(7,213,000)	(7,321,000)
Net cash used in financing activities	(9,958,000)	(21,440,000)
Net increase (decrease) in cash and cash equivalents	33,299,000	(60,366,000)
Cash and cash equivalents at beginning of period	4,953,000	84,347,000
Cash and cash equivalents at end of period	38,252,000	23,981,000
Cash paid during the period
Interest	1,645,000	1,961,000
Income taxes		$ 2,000

XML

Stockholders' Equity

9 Months Ended

Jun. 30, 2013

Stockholders' Equity

Note 14: Stockholders’ Equity

In December 2012, the Board of Directors of the Company approved the payment of a special accelerated annual dividend of $0.08 per share to shareholders of record on December 24, 2012. The aggregate dividend of $1,030,000 was paid on December 28, 2012.

On March 9, 2012, the Company adopted a Rule 10b5-1 Plan in conjunction with its share repurchase program. The Board of Directors approved the repurchase of up to $20 million of the Company’s common stock, which was effective through March 11, 2013. The Company purchased approximately 885,000 shares at an aggregate purchase price of approximately $7,948,000 under the plan. Additionally, in June 2012, the Company purchased 1.0 million shares of its common stock for $9.4 million in a privately negotiated transaction outside of the Rule 10b5-1 Plan.

As of June 30, 2013, stockholders’ equity includes an amount for other comprehensive loss of $697,000, which reflects unrealized losses in available-for-sale securities. In addition, $207,000 related to the non-controlling interest in Pegasus Funding, LLC has been included in stockholders’ equity.

XML

Stock Option Plans (Detail) (USD $)	3 Months Ended			9 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options at the beginning of period, Shares	1,655,871	1,499,471	1,649,538	1,499,471	1,294,271
Options granted, Shares	50,000	160,000		210,000	360,000
Options exercised, Shares	(25,900)		(16,000)	(29,500)	(19,333)
Options forfeited, Shares			(6,900)		(8,300)
Options canceled Shares	(50,000)			(50,000)
Outstanding options at the end of period, Shares	1,629,971		1,626,638	1,629,971	1,626,638
Exercisable options at the end of period, Shares	1,112,037		1,126,871	1,112,037	1,126,871
Outstanding options at the beginning of period, Weighted Average Exercise Price	$ 11.12	$ 11.27	$ 10.64	$ 11.27	$ 11.41
Options granted, Weighted Average Exercise Price	$ 8.69			$ 9.36	$ 7.87
Options exercised, Weighted Average Exercise Price	$ 3.06		$ 2.95	$ 3.51	$ 3.15
Options forfeited, Weighted Average Exercise Price			$ 6.05		$ 6.02
Options cancelled, Weighted Average Exercise Price	$ 7.77			$ 7.77
Outstanding options at the end of period, Weighted Average Exercise Price	$ 11.27		$ 10.75	$ 11.27	$ 10.75
Exercisable options at the end of period, Weighted Average Exercise Price	$ 12.57		$ 12.00	$ 12.57	$ 12.00

XML

Commitments and Contingencies

9 Months Ended

Jun. 30, 2013

Commitments and Contingencies

Note 8: Commitments and Contingencies

Employment Agreements

In January 2007, the Company entered into an employment agreement (the “Employment Agreement”) with Gary Stern, its Chairman, President and Chief Executive Officer, which expired on December 31, 2009. Mr. Stern is continuing in his current roles at the discretion of the Board of Directors until a new agreement is signed.

Leases

The Company leases its facilities in Englewood Cliffs, New Jersey, Houston, Texas and New York, New York. Please refer to our consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012, as filed with the SEC, for additional information.

Litigation

In the ordinary course of its business, the Company is involved in numerous legal proceedings. The Company regularly initiates collection lawsuits against consumers, using its network of third party law firms. In addition, consumers occasionally initiate litigation against the Company, alleging that the Company has violated a federal or state law in the process of collecting their account. The Company does not believe that these matters are material to its business and financial condition. The Company is not involved in any material litigation in which it is a defendant.

XML

Non Recourse Debt - Additional Information (Detail) (USD $)	1 Months Ended			3 Months Ended	9 Months Ended	12 Months Ended			3 Months Ended
	Dec. 30, 2011	Oct. 26, 2010	Mar. 31, 2007	Jun. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Jun. 30, 2013 Fifth Amendment	Sep. 30, 2012 Fifth Amendment	Dec. 31, 2011 Bank Leumi Credit Agreement	Mar. 31, 2007 Receivables Financing Agreement
Debt Instrument [Line Items]
Receivables Financing Agreement										$ 227,000,000
Portfolio Purchase had a purchase price			300,000,000
Net payments recovered			Plus 20% of net payments after Palisades XVI recovers 150% of its purchase price plus cost of funds
Accrued interest			170 basis points over LIBOR
Receivables financing agreement, consecutive months			3 years
Expiration date					Apr. 14, 2014
Effective date of agreement		Oct. 14, 2010
Monthly total payment					750,000
Company's guaranty credit enhancement		8,700,000
Loan outstanding over the borrowing base		105.00%
Aggregate minimum repayment obligations 2013				2,300,000	2,300,000
Aggregate minimum repayment obligations 2014				52,000,000	52,000,000
Revolving debt level Liquidity				54,300,000	54,300,000	61,500,000
Applicable interest rate							3.69%	3.73%
Average interest rate				3.70%	3.71%	3.76%
Average debt obligation					57,700,000	66,800,000
Principal Credit Facility	$ 20,000,000
Term of Credit Facility	Feb. 23, 2013
Accrued interest (Prime Rate)									0.50%

XML

Summary of Outstanding Options (Detail) (USD $)	9 Months Ended
	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Sep. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding	1,629,971	1,655,871	1,499,471	1,626,638	1,649,538	1,294,271
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	5 years 7 months 6 days
Options Outstanding, Weighted Average Exercise Price	$ 11.27	$ 11.12	$ 11.27	$ 10.75	$ 10.64	$ 11.41
Options Exercisable, Number Exercisable	1,112,037			1,126,871
Options Exercisable, Weighted Average Exercise Price	$ 12.57			$ 12.00
$2.8751 - $ 5.7500
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 2.8751
Range of Exercise Price, Upper Range	$ 5.7500
Options Outstanding, Number Outstanding	25,800
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	5 years 10 months 24 days
Options Outstanding, Weighted Average Exercise Price	$ 2.95
Options Exercisable, Number Exercisable	25,800
Options Exercisable, Weighted Average Exercise Price	$ 2.95
$5.7501 - $8.6250
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 5.7501
Range of Exercise Price, Upper Range	$ 8.6250
Options Outstanding, Number Outstanding	790,900
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	7 years 8 months 12 days
Options Outstanding, Weighted Average Exercise Price	$ 7.81
Options Exercisable, Number Exercisable	482,966
Options Exercisable, Weighted Average Exercise Price	$ 7.77
$8.6251 - $14.3750
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 8.6251
Range of Exercise Price, Upper Range	$ 14.3750
Options Outstanding, Number Outstanding	260,000
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	9 years 3 months 18 days
Options Outstanding, Weighted Average Exercise Price	$ 9.28
Options Exercisable, Number Exercisable	50,000
Options Exercisable, Weighted Average Exercise Price	$ 11.50
$14.3751 - $17.2500
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 14.3751
Range of Exercise Price, Upper Range	$ 17.2500
Options Outstanding, Number Outstanding	198,611
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	4 months 24 days
Options Outstanding, Weighted Average Exercise Price	$ 14.88
Options Exercisable, Number Exercisable	198,611
Options Exercisable, Weighted Average Exercise Price	$ 14.88
$17.2501 - $20.1250
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 17.2501
Range of Exercise Price, Upper Range	$ 20.1250
Options Outstanding, Number Outstanding	339,660
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	1 year 3 months 18 days
Options Outstanding, Weighted Average Exercise Price	$ 18.23
Options Exercisable, Number Exercisable	339,660
Options Exercisable, Weighted Average Exercise Price	$ 18.23
$25.8751 - $28.7500
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Price, Lower Range	$ 25.8751
Range of Exercise Price, Upper Range	$ 28.7500
Options Outstanding, Number Outstanding	15,000
Options Outstanding, Weighted Average Remaining Contractual Life (in Years)	3 years 6 months
Options Outstanding, Weighted Average Exercise Price	$ 28.75
Options Exercisable, Number Exercisable	15,000
Options Exercisable, Weighted Average Exercise Price	$ 28.75

XML

Certificates of Deposit (Detail) (USD $)	Jun. 30, 2013	Sep. 30, 2012
Investments [Line Items]
Certificates of deposit in banks	$ 8,764,000	$ 42,682,000

XML

Business and Basis of Presentation (Policies)

9 Months Ended

Jun. 30, 2013

Business

Business

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), Pegasus Funding, LLC (“Pegasus”) and other subsidiaries, not all wholly owned, and not considered material (the “Company”) is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged-off receivables, semi-performing receivables and performing receivables. The primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Performing receivables are accounts where the debtor is making regular monthly payments that may or may not have been delinquent in the past. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of the Company’s distressed consumer receivables are MasterCard(R), Visa(R), other credit card accounts, and telecommunication accounts which were charged-off by the issuers for non-payment. The Company acquires these portfolios at substantial discounts from their face values. The discounts are based on the characteristics (issuer, account size, debtor residence and age of debt) of the underlying accounts of each portfolio.

In addition, the Company, through majority-owned subsidiaries Pegasus Funding, LLC, and BP Case Management, LLC, invests in funding personal injury and matrimonial claims, respectively.

Basis of Presentation

Basis of Presentation

The condensed consolidated balance sheet as of June 30, 2013, the condensed consolidated statements of operations for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statements of comprehensive (loss) income for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statement of stockholders’ equity as of and for the nine months ended June 30, 2013 and the condensed consolidated statements of cash flows for the nine month periods ended June 30, 2013 and 2012 are unaudited. The September 30, 2012 financial information included in this report has been extracted from our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly our financial position at June 30, 2013 and September 30, 2012, the results of operations for the nine and three month periods ended June 30, 2013 and 2012 and cash flows for the nine month periods ended June 30, 2013 and 2012 have been made. The results of operations for the nine and three month periods ended June 30, 2013 and 2012 are not necessarily indicative of the operating results for any other interim period or the full fiscal year.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2012 filed with the SEC.

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02 “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”. The amendments require an entity to present, either in the income statement or the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required under U.S. Generally Accepted Accounting Principles (“GAAP”) to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety, an entity is required to cross-reference to other disclosures that might provide additional details about the amounts. This ASU was effective for annual and interim periods beginning January 1, 2013. Adoption of the ASU did not have a significant effect on the Company’s consolidated financial statements (see Note 3: Investments).

In December 2011, the FASB issued ASU No. 2011-12, amended ASC Topic 220 “Comprehensive Income.” The amendments defer certain disclosure requirements regarding reclassifications within ASU No. 2011-05, until the FASB can deliberate further on these requirements. The amendments in this update are effective for the annual period beginning on or after December 15, 2012 and must be applied retrospectively. The Company has chosen to early-adopt ASU 2011-12 and implementation of this guidance has not had a material effect on the Company’s consolidated financial statements.

Concentration of Credit Risk - Cash

Concentration of Credit Risk – Cash

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with seven banks at June 30, 2013 that exceeded the balance insured by the FDIC by approximately $35.2 million.

Subsequent Events

Subsequent Events

The Company has evaluated events and transactions occurring subsequent to the Condensed Balance Sheet date of June 30, 2013, for items that should potentially be recognized or disclosed in these financial statements. On August 7, 2013, the Company entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with the Bank of Montreal (“BMO”) as an Amendment to the Receivables Financing Agreement. See Note 16 for more information.

XML

Subsequent Event

9 Months Ended

Jun. 30, 2013

Subsequent Event

Note 16: Subsequent Event

On August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with BMO as an amendment to the Receivables Financing Agreement. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next $15 million of collections from the Portfolio Purchase, less certain credits for payments made prior to the consummation of the Settlement Agreement, the Company is entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO will have the right to receive 30% of future net collections. Palisades XVI was in technical violation of the borrowing base covenant at June 30, 2013. The covenant was eliminated entirely from the Settlement Agreement.

XML

Other Investments - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	May 18, 2012
Other Investments [Line Items]
Earnings attributable to non-controlling interest	$ 53,000	$ 17,000	$ 176,000	$ 66,000
Revolving line of credit					1,000,000
Bearing interest at prime rate, with initial term					Twenty-four months
Company's investment in cases through BPCM	989,000		989,000
Balance Point Case Management Llc
Other Investments [Line Items]
Revenue	0	0	0	165,000
Pegasus Legal Funding LLC
Other Investments [Line Items]
Earnings attributable to non-controlling interest	53,000	17,000	176,000	66,000
Earnings in interest and fees	2,300,000	400,000	4,900,000	1,000,000
Company's investment in personal injury			$ 32,300,000	$ 13,000,000

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Jun. 30, 2013

Estimated Fair Value of Company's Financial Instruments

The estimated fair value of the Company’s financial instruments is summarized as follows:

	June 30, 2013				September 30, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Available-for-sale investments (Level 1)	$	58,336,000	$	58,336,000	$	58,712,000	$	58,712,000
Certificates of deposit (Level 2)		8,764,000		8,764,000		42,682,000		42,682,000
Consumer receivables acquired for liquidation (Level 3)		62,594,000		82,887,000		86,887,000		100,706,000
Financial liabilities
Non-Recourse Debt (Level 2)		54,250,000		28,000,000		61,463,000		61,463,000

XML

Changes in Balance Sheet Account of Consumer Receivables Acquired for Liquidation (Detail) (USD $)	3 Months Ended				9 Months Ended
	Jun. 30, 2013		Jun. 30, 2012		Jun. 30, 2013		Jun. 30, 2012
Consumer Receivables Acquired For Liquidation [Line Items]
Balance, beginning of period	$ 74,824,000		$ 101,836,000		$ 86,887,000		$ 115,195,000
Acquisitions of receivable portfolios	3,340,000				3,340,000		2,675,000
Net cash collections from collection of consumer receivables acquired for liquidation	(13,418,000)		(18,464,000)		(40,014,000)		(54,069,000)
Cash collections represented by account sales of consumer receivables acquired for liquidation	(2,007,000)		(11,000)		(2,024,000)		(89,000)
Transfer to cost recovery			(1,840,000)				(1,840,000)
Impairment	(10,148,000)		(122,000)		(12,351,000)		(733,000)
Finance income recognized	10,003,000	[1]	10,501,000	[2]	26,756,000	[3]	30,761,000	[4]
Balance, end of period	62,594,000		93,740,000		62,594,000		93,740,000
Finance income as a percentage of collections	64.80%		56.80%		63.60%		56.80%
Interest Method
Consumer Receivables Acquired For Liquidation [Line Items]
Balance, beginning of period	6,813,000		24,897,000		12,326,000		31,193,000
Acquisitions of receivable portfolios	3,340,000				3,340,000		1,278,000
Net cash collections from collection of consumer receivables acquired for liquidation	(8,611,000)		(12,672,000)		(26,901,000)		(38,550,000)
Cash collections represented by account sales of consumer receivables acquired for liquidation	(970,000)		(11,000)		(987,000)		(89,000)
Transfer to cost recovery			(6,484,000)				(6,484,000)
Impairment			(122,000)		(2,203,000)		(733,000)
Finance income recognized	8,534,000	[1]	9,648,000	[2]	23,531,000	[3]	28,641,000	[4]
Balance, end of period	9,106,000		15,256,000		9,106,000		15,256,000
Finance income as a percentage of collections	89.10%		76.10%		84.40%		74.10%
Cost Recovery Method
Consumer Receivables Acquired For Liquidation [Line Items]
Balance, beginning of period	68,011,000		76,939,000		74,561,000		84,002,000
Acquisitions of receivable portfolios							1,397,000
Net cash collections from collection of consumer receivables acquired for liquidation	(4,807,000)		(5,792,000)		(13,113,000)		(15,519,000)
Cash collections represented by account sales of consumer receivables acquired for liquidation	(1,037,000)				(1,037,000)
Transfer to cost recovery			6,484,000				6,484,000
Impairment	(10,148,000)				(10,148,000)
Finance income recognized	1,469,000	[1]	853,000	[2]	3,225,000	[3]	2,120,000	[4]
Balance, end of period	$ 53,488,000		$ 78,484,000		$ 53,488,000		$ 78,484,000
Finance income as a percentage of collections	25.10%		14.70%		22.80%		13.70%

[1] Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

[2] Includes approximately $9.6 million derived from fully amortized portfolios.

[3] Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales which occurred in the third quarter.

[4] Includes approximately $27.4 million derived from fully amortized portfolios.

XML

Income Recognition and Impairments - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Recognition And Impairments [Line Items]
Impairment charges	$ 10,148,000	$ 122,000	$ 12,351,000	$ 733,000
Recovering percentage from invested capital			100.00%
Purchase of Portfolio			Acquired since the beginning of fiscal year 2009
Expected time period for recovering of capital			7 years
Increase from expected time period for recovering of capital			5 years
Maximum
Income Recognition And Impairments [Line Items]
Recovering percentage from invested capital			140.00%
Time frame for recovering invested capital			29 months	24 months
Minimum
Income Recognition And Impairments [Line Items]
Recovering percentage from invested capital			130.00%
Time frame for recovering invested capital			28 months	18 months

XML

Net Income (Loss) per Share Attributable to Asta Funding, Inc. (Tables)

9 Months Ended

Jun. 30, 2013

Computation of Basic and Diluted Per Share

The following table presents the computation of basic and diluted per share data for the nine and three months ended June 30, 2013 and 2012:

	Nine Months Ended June 30,
	2013						2012
	Net Income		Weighted Average Shares		Per Share Amount		Net Income		Weighted Average Shares		Per Share Amount
Basic	$	733,000		12,946,521	$	0.06	$	8,485,000		14,440,224	$	0.59
Effect of Dilutive Stock		—		271,382		—		—		243,417		(0.01	)
Diluted	$	733,000		13,217,903	$	0.06	$	8,485,000		14,683,641	$	0.58

	Three Months Ended June 30,
	2013								2012
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Basic	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,170,575	$	0.22
Effect of Dilutive Stock		—			—		—			—		258,468		(0.01	)
Diluted	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,429,043	$	0.21

XML

Changes in Accretable Yield (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Consumer Receivables Acquired For Liquidation [Line Items]
Balance at beginning of period	$ 942,000	$ 6,107,000	$ 2,086,000	$ 7,473,000
Income recognized on finance receivables	(8,534,000)	(9,543,000)	(23,531,000)	(28,536,000)
Additions representing expected revenue from purchases	983,000		983,000	362,000
Transfer to cost recovery		(1,840,000)		(1,840,000)
Reclassifications from nonaccretable difference	8,021,000	8,615,000	21,874,000	25,880,000
Balance at end of period	$ 1,412,000	$ 3,339,000	$ 1,412,000	$ 3,339,000

XML

Fair Value of Financial Instruments

9 Months Ended

Jun. 30, 2013

Fair Value of Financial Instruments

Note 15: Fair Value of Financial Instruments

Disclosures about Fair Value of Financial Instruments

FASB ASC 825, Financial Instruments, (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

The estimated fair value of the Company’s financial instruments is summarized as follows:

	June 30, 2013				September 30, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Available-for-sale investments (Level 1)	$	58,336,000	$	58,336,000	$	58,712,000	$	58,712,000
Certificates of deposit (Level 2)		8,764,000		8,764,000		42,682,000		42,682,000
Consumer receivables acquired for liquidation (Level 3)		62,594,000		82,887,000		86,887,000		100,706,000
Financial liabilities
Non-Recourse Debt (Level 2)		54,250,000		28,000,000		61,463,000		61,463,000

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments:

Certificates of deposit — The carrying amount approximates fair value due to the short-term nature of the deposits.

Available-for-sale investments – The available-for-sale securities consist of mutual funds that are valued based on quoted prices in active markets.

Consumer receivables acquired for liquidation – The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of collections for consumer receivables based on variables fully described in Note 4: Consumer Receivables Acquired for Liquidation. These cash flows are discounted to determine the fair value.

Non-Recourse Debt – Carries a variable rate. The fair value has been determined as a result of the Settlement Agreement discussed in Note 16.

Fair Value Hierarchy

The Company recorded its available-for-sale investments at estimated fair value on a recurring basis. The accompanying consolidated financial statements include estimated fair value information regarding its available-for sale investments as of March 31, 2013, as required by FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs, when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement.

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are not active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3- Unobservable inputs that are supported by little or no market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.

The Company’s available-for-sale investments are classified as Level 1 financial instruments based on the classifications described above. The Company did not have any transfers into (out of) Level 1 investments during the periods June 30, 2013 and September 30, 2012. The Company had no Level 2 or Level 3 available-for-sale investments during the periods June 30, 2013 and September 30, 2012.

XML

Condensed Consolidated Statements of Comprehensive (Loss) Income (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Comprehensive (loss) income is as follows:
Net (loss) income	$ (2,684,000)	$ 3,065,000	$ 909,000	$ 8,551,000
Net unrealized securities (loss) / gain, net of tax benefit / (taxes) of $415,000 and ($74,000), during the three month periods ended June 30, 2013 and 2012, respectively, and $543,000 and ($337,000), during the nine month periods ended June 30, 2013 and 2012, respectively.	(631,000)	110,000	(822,000)	500,000
Reclassification adjustments for securities sold, net of tax benefit of $5,000 and $54,000, during the three month periods ended June 30, 2013 and 2012, respectively, and $76,000 and $101,000, during the nine month periods ended June 30, 2013 and 2012, respectively.	(12,000)	(80,000)	(116,000)	(150,000)
Other comprehensive (loss) income	(643,000)	30,000	(938,000)	350,000
Total comprehensive (loss) income	$ (3,327,000)	$ 3,095,000	$ (29,000)	$ 8,901,000

XML

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Treasury Stock		Non- Controlling Interest
Beginning balance at Sep. 30, 2012	$ 168,521,000	$ 148,000	$ 77,024,000	$ 107,303,000	$ 241,000	$ (16,226,000)	[1]	$ 31,000
Beginning balance (in shares) at Sep. 30, 2012		14,778,956
Exercise of options (in shares)	29,500	29,500
Exercise of options	103,000		103,000
Stock based compensation expense	1,498,000		1,498,000
Restricted stock (in shares)		102,321
Restricted stock		1,000	(1,000)
Dividends	(1,030,000)			(1,030,000)
Purchase of treasury stock	(1,579,000)					(1,579,000)	[1]
Net income	909,000			733,000				176,000
Unrealized loss on marketable securities	(938,000)				(938,000)
Ending balance at Jun. 30, 2013	$ 167,484,000	$ 149,000	$ 78,624,000	$ 107,006,000	$ (697,000)	$ (17,805,000)	[1]	$ 207,000
Ending balance (in shares) at Jun. 30, 2013		14,910,777

[1] Treasury shares are as follows: September 30, 2012, 1,772,038; Purchase of treasury stock, 171,700; June 30, 2013, 1,943,738.

XML

Business and Basis of Presentation

9 Months Ended

Jun. 30, 2013

Business and Basis of Presentation

Note 1: Business and Basis of Presentation

Business

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), Pegasus Funding, LLC (“Pegasus”) and other subsidiaries, not all wholly owned, and not considered material (the “Company”) is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged-off receivables, semi-performing receivables and performing receivables. The primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Performing receivables are accounts where the debtor is making regular monthly payments that may or may not have been delinquent in the past. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of the Company’s distressed consumer receivables are MasterCard(R), Visa(R), other credit card accounts, and telecommunication accounts which were charged-off by the issuers for non-payment. The Company acquires these portfolios at substantial discounts from their face values. The discounts are based on the characteristics (issuer, account size, debtor residence and age of debt) of the underlying accounts of each portfolio.

In addition, the Company, through majority-owned subsidiaries Pegasus Funding, LLC, and BP Case Management, LLC, invests in funding personal injury and matrimonial claims, respectively.

Basis of Presentation

The condensed consolidated balance sheet as of June 30, 2013, the condensed consolidated statements of operations for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statements of comprehensive (loss) income for the nine and three month periods ended June 30, 2013 and 2012, the condensed consolidated statement of stockholders’ equity as of and for the nine months ended June 30, 2013 and the condensed consolidated statements of cash flows for the nine month periods ended June 30, 2013 and 2012 are unaudited. The September 30, 2012 financial information included in this report has been extracted from our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly our financial position at June 30, 2013 and September 30, 2012, the results of operations for the nine and three month periods ended June 30, 2013 and 2012 and cash flows for the nine month periods ended June 30, 2013 and 2012 have been made. The results of operations for the nine and three month periods ended June 30, 2013 and 2012 are not necessarily indicative of the operating results for any other interim period or the full fiscal year.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2012 filed with the SEC.

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02 “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”. The amendments require an entity to present, either in the income statement or the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required under U.S. Generally Accepted Accounting Principles (“GAAP”) to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety, an entity is required to cross-reference to other disclosures that might provide additional details about the amounts. This ASU was effective for annual and interim periods beginning January 1, 2013. Adoption of the ASU did not have a significant effect on the Company’s consolidated financial statements (see Note 3: Investments).

In December 2011, the FASB issued ASU No. 2011-12, amended ASC Topic 220 “Comprehensive Income.” The amendments defer certain disclosure requirements regarding reclassifications within ASU No. 2011-05, until the FASB can deliberate further on these requirements. The amendments in this update are effective for the annual period beginning on or after December 15, 2012 and must be applied retrospectively. The Company has chosen to early-adopt ASU 2011-12 and implementation of this guidance has not had a material effect on the Company’s consolidated financial statements.

Concentration of Credit Risk – Cash

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with seven banks at June 30, 2013 that exceeded the balance insured by the FDIC by approximately $35.2 million.

Subsequent Events

The Company has evaluated events and transactions occurring subsequent to the Condensed Balance Sheet date of June 30, 2013, for items that should potentially be recognized or disclosed in these financial statements. On August 7, 2013, the Company entered into a Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) with the Bank of Montreal (“BMO”) as an Amendment to the Receivables Financing Agreement. See Note 16 for more information.

XML

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical)	9 Months Ended	12 Months Ended
	Jun. 30, 2013	Sep. 30, 2012
Treasury stock, shares	1,943,738	1,772,038
Purchase of treasury stock	1,943,738	171,700

XML

Changes in Balance Sheet Account of Consumer Receivables Acquired for Liquidation (Parenthetical) (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Consumer Receivables Acquired For Liquidation [Line Items]
Fully amortized portfolios	$ 9.7	$ 9.6	$ 25.8	$ 27.4
Account Sales
Consumer Receivables Acquired For Liquidation [Line Items]
Fully amortized portfolios	$ 1.6		$ 1.6

XML

Investments (Tables)

9 Months Ended

Jun. 30, 2013

Available-for-Sale

Investments classified as available-for-sale at June 30, 2013 and September 30, 2012 consist of the following:

Mutual Funds	Cost		Unrealized Gains		Unrealized Losses			Fair Value
June 30, 2013	$	55,489,000	$	—	$	(1,153,000	)	$	58,336,000
September 30, 2012	$	58,308,000	$	404,000	$	—		$	58,712,000

Certificates of Deposit

Certificates of deposit consist of the following:

	June 30,		September 30,
	2013		2012
Certificates of deposit in banks	$	8,764,000	$	42,682,000

XML

Stock Based Compensation (Tables)

9 Months Ended

Jun. 30, 2013

Weighted Average Assumptions Used in Option Pricing Model

The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.10	%
Expected term (years)	6.2
Expected volatility	99.7	%
Dividend yield	0.92	%

The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.16	%
Expected term (years)	6.0
Expected volatility	101.0	%
Dividend yield	1.67	%

XML

Investments - Additional Information (Detail) (USD $)	3 Months Ended	9 Months Ended		12 Months Ended	3 Months Ended	9 Months Ended
	Dec. 31, 2012	Jun. 30, 2013 Investment	Jun. 30, 2012 Investment	Sep. 30, 2012 Investment	Jun. 30, 2013 Investment One Investment	Jun. 30, 2013 Available-for-sale Securities	Jun. 30, 2013 Liquidated certificate of deposit
Investments [Line Items]
Number of investments sold		3	2		1
Realized gain of investment		$ 192,000	$ 251,000		$ 17,000
Capital gains received	225,000
Total income related to available-for sale investments						417,000
Number of unrealized loss position in investment		6
Number of unrealized gain position in investment				6
Substantial penalties for withdrawal prior to maturity		1 year
Number of certificate of deposit liquidated		2
Liquidated certificate of deposits (plus accrued interest)		$ 8,764,000		$ 42,682,000			$ 33,918,000

XML

Stock Option Plans - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended		9 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 Restricted stock to Chief Executive Officer	Jun. 30, 2012 Restricted stock to Chief Executive Officer	Jun. 30, 2013 Restricted stock to Chief Executive Officer	Jun. 30, 2012 Restricted stock to Chief Executive Officer	Jun. 30, 2013 Employee Stock Option	Jun. 30, 2012 Employee Stock Option	Jun. 30, 2013 Employee Stock Option	Jun. 30, 2012 Employee Stock Option	Jun. 30, 2013 Nonvested Option	Jun. 30, 2013 Nonvested Option	Jun. 30, 2013 Equity Compensation Plan Common Stock	Jun. 30, 2013 Two Thousand And Twelve Plan	Dec. 31, 2012 Two Thousand And Twelve Plan	Jun. 30, 2013 Two Thousand And Twelve Plan Employee	Dec. 31, 2012 Two Thousand And Twelve Plan Common Stock	Jun. 30, 2013 Nineteen Ninety Five Plan	Jun. 30, 2013 Nineteen Ninety Five Plan Common Stock	Jun. 30, 2013 Two Thousand And Two Plan	Jun. 30, 2013 Two Thousand And Two Plan Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock authorized															1,000,000				2,000,000		1,840,000		1,000,000
Options granted, Shares	50,000	160,000	210,000	360,000												50,000	262,321
Eligible employees																		58
Number of shares available																1,687,679		1,687,679
Stock option awarded stock issued															0						0		0
Stock Option Plan expiration date															Mar. 21, 2012					Sep. 14, 2005		Mar. 05, 2012
Stock-based employee compensation					$ 81,000	$ 21,000	$ 191,000	$ 64,000	$ 532,000	$ 416,000	$ 1,307,000	$ 1,117,000	$ 161,000	$ 161,000
Unrecognized compensation cost					805,000		805,000		2,378,000		2,378,000
Intrinsic value of the stock options exercised	161,000		172,000
Unrecognized compensation cost, weighted average remaining period for recognition	2 years				2 years 6 months
Intrinsic value, option outstanding	810,000		810,000
Intrinsic value, option exercisable	573,000		573,000
Fair value, option exercisable	241,000		276,000
Remaining contractual life of exercisable options	4 years 1 month 6 days
Fair Value, option vested	$ 144,000		$ 1,259,000

XML

Income Taxes - Additional Information (Detail)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Taxes [Line Items]
Provision for income tax expense (benefit)	(40.90%)	40.30%	40.50%	40.30%
Corporate federal income tax returns subject to examination by the IRS			3 years
State income tax returns subjected to examine			4 years

XML

Collections on Gross Basis Less Commissions And Fees (Parenthetical) (Detail)	9 Months Ended
	Jun. 30, 2013
Consumer Receivables Acquired For Liquidation [Line Items]
Fee charged on portfolio purchase	3.00%

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2013	Sep. 30, 2012
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares issued	14,910,777	14,778,956
Common stock, shares outstanding	12,967,039	13,006,918
Treasury stock, shares	1,943,738	1,772,038

XML

Consumer Receivables Acquired for Liquidation

9 Months Ended

Jun. 30, 2013

Consumer Receivables Acquired for Liquidation

Note 4: Consumer Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at their net estimated realizable value and consist primarily of defaulted consumer loans to individuals throughout the country and in Central and South America.

The Company accounts for its investments in consumer receivable portfolios, using either:

• the interest method; or

• the cost recovery method.

The Company accounts for its investment in finance receivables using the interest method, under the guidance of FASB Accounting Standards Codification (“ASC”), Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality, (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision.

Once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller). ASC 310 requires that the excess of the contractual cash flows over expected cash flows not be recognized as an adjustment of revenue or expense or on the balance sheet. ASC 310 initially freezes the internal rate of return, referred to as IRR, estimated when the accounts receivable are purchased, as the basis for subsequent impairment testing. Significant increases in actual or expected future cash flows may be recognized prospectively through an upward adjustment of the IRR over a portfolio’s remaining life. Any increase to the IRR then becomes the new benchmark for impairment testing. Rather than lowering the estimated IRR if the collection estimates are not received or projected to be received, the carrying value of a pool would be impaired, or written down, to maintain the then current IRR. Under the interest method, income is recognized on the effective yield method based on the actual cash collected during a period and future estimated cash flows and timing of such collections and the portfolio’s cost. Revenue arising from collections in excess of anticipated amounts attributable to timing differences is deferred until such time as a review results in a change in the expected cash flows. The estimated future cash flows are reevaluated quarterly.

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.

The Company has liquidating experience in the fields of distressed credit card receivables, telecommunication receivables, consumer loan receivables, retail installment contracts, consumer receivables, litigation-related medical accounts, and auto deficiency receivables. The Company uses the interest method for accounting for asset acquisitions within these classes of receivables when it believes it can reasonably estimate the timing of the cash flows. In those situations where the Company diversifies its acquisitions into other asset classes in which the Company does not possess the same expertise or history, or the Company cannot reasonably estimate the timing of the cash flows, the Company utilizes the cost recovery method of accounting for those portfolios of receivables. At June 30, 2013, approximately $9.1 million of the consumer receivables acquired for liquidation are accounted for using the interest method, while approximately $53.5 million are accounted for using the cost recovery method, of which $46.3 million is concentrated in one portfolio, a $300 million portfolio purchase in March 2007 (the “Portfolio Purchase”).

The Company aggregates portfolios of receivables acquired sharing specific common characteristics which were acquired within a given quarter. The Company currently considers for aggregation portfolios of accounts, purchased within the same fiscal quarter, that generally meet the following characteristics:

• same issuer/originator;

• same underlying credit quality;

• similar geographic distribution of the accounts;

• similar age of the receivable; and

• same type of asset class (credit cards, telecommunication, etc.).

The Company uses a variety of qualitative and quantitative factors to estimate collections and the timing thereof. This analysis includes the following variables:

• the number of collection agencies previously attempting to collect the receivables in the portfolio;

• the average balance of the receivables, as higher balances might be more difficult to collect, while low balances might not be cost effective to collect;

• the age of the receivables, as older receivables might be more difficult to collect or might be less cost effective. On the other hand, the passage of time, in certain circumstances, might result in higher collections due to changing life events of some individual debtors;

• past history of performance of similar assets;

• time since charge-off;

• payments made since charge-off;

• the credit originator and its credit guidelines;

• the Company’s ability to analyze accounts and resell accounts that meet its criteria for resale;

• the locations of the debtors, as there are better states to attempt to collect in and, ultimately, the Company has better predictability of the liquidations and the expected cash flows. Conversely, there are states where the liquidation rates are not as favorable and that is factored into the Company’s cash flow analysis;

• financial condition of the seller;

• jobs or property of the debtors found within portfolios. In the Company’s business model, this is of particular importance as debtors with jobs or property are more likely to repay their obligation and, conversely, debtors without jobs or property are less likely to repay their obligation; and

• the ability to obtain timely customer statements from the original issuer.

The Company obtains and utilizes, as appropriate, input, including, but not limited to, monthly collection projections and liquidation rates from our third party collection agencies and attorneys, as further evidentiary matter, to assist in evaluating and developing collection strategies and in evaluating and modeling the expected cash flows for a given portfolio.

The following tables summarize the changes in the balance sheet of the investment in receivable portfolios during the following periods.

	For the Nine Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	12,326,000		$	74,561,000		$	86,887,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collection of consumer receivables acquired for liquidation		(26,901,000	)		(13,113,000	)		(40,014,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(987,000	)		(1,037,000	)		(2,024,000	)
Impairment		(2,203,000	)		(10,148,000	)		(12,351,000	)
Finance income recognized (1)		23,531,000			3,225,000			26,756,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		84.4	%		22.8	%		63.6	%

(1) Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales which occurred in the third quarter.

	For the Nine Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	31,193,000		$	84,002,000		$	115,195,000
Acquisitions of receivable portfolios		1,278,000			1,397,000			2,675,000
Net cash collections from collection of consumer receivables acquired for liquidation		(38,550,000	)		(15,519,000	)		(54,069,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(89,000	)		—			(89,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(733,000	)		—			(733,000	)
Finance income recognized (1)		28,641,000			2,120,000			30,761,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		74.1	%		13.7	%		56.8	%

(1) Includes approximately $27.4 million derived from fully amortized portfolios.

	For the Three Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	6,813,000		$	68,011,000		$	74,824,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collections of consumer receivables acquired for liquidation		(8,611,000	)		(4,807,000	)		(13,418,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(970,000	)		(1,037,000	)		(2,007,000	)
Impairment		—			(10,148,000	)		(10,148,000	)
Finance income recognized (1)		8,534,000			1,469,000			10,003,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		89.1	%		25.1	%		64.8	%

(1) Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

	For the Three Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	24,897,000		$	76,939,000		$	101,836,000
Net cash collections from collections of consumer receivables acquired for liquidation		(12,672,000	)		(5,792,000	)		(18,464,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(11,000	)		—			(11,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(122,000	)		—			(122,000	)
Finance income recognized (1)		9,648,000			853,000			10,501,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		76.1	%		14.7	%		56.8	%

(1) Includes approximately $9.6 million derived from fully amortized portfolios.

As of June 30, 2013, the Company had $62.6 million in Consumer Receivables acquired for Liquidation, of which $9.1 million are being accounted for on the interest method. Based upon current projections, net cash collections applied to principal for interest method portfolios will be as follows for the twelve months in the periods ending:

September 30, 2013 (three months ending)	$	2,294,000
September 30, 2014		3,389,000
September 30, 2015		952,000
September 30, 2016		736,000
September 30, 2017		576,000
September 30, 2018		485,000
September 30, 2019		420,000
September 30, 2020		254,000
Total	$	9,106,000

Accretable yield represents the amount of income the Company can expect to generate over the remaining life of its existing portfolios based on estimated future net cash flows as of June 30, 2013. The Company adjusts the accretable yield upward when it believes, based on available evidence, that portfolio collections will exceed amounts previously estimated. Changes in accretable yield for the nine months and three months ended June 30, 2013 and 2012 are as follows:

	For the Nine Months Ended June 30,
	2013			2012
Balance at beginning of period	$	2,086,000		$	7,473,000
Income recognized on finance receivables		(23,531,000	)		(28,536,000	)
Additions representing expected revenue from purchases		983,000			362,000
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		21,874,000			25,880,000
Balance at end of period	$	1,412,000		$	3,339,000
	For the Three Months Ended June 30,
	2013			2012
Balance at beginning of period	$	942,000		$	6,107,000
Income recognized on finance receivables		(8,534,000	)		(9,543,000	)
Additions representing expected revenue from purchases		983,000			—
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		8,021,000			8,615,000
Balance at end of period	$	1,412,000		$	3,339,000

During both the three and nine month period ended June 30, 2013, the Company purchased $53.5 million of face value receivables at a cost of approximately $3.3 million. During the nine month period ended June 30, 2012, the Company purchased $6.0 million of face value receivables at a cost of $2.7 million. There were no portfolio purchases during the three month period ended June 30, 2012. The current fiscal year purchases were for credit card receivables, while those in the prior fiscal year were in the litigation related category.

The following table summarizes collections on a gross basis less commissions and fees for the nine and three month periods ended June 30, 2013 and 2012, respectively:

	For the Nine Months Ended June 30,
	2013		2012
Gross collections (1)	$	66,371,000	$	83,379,000
Less: commissions and fees (2)		24,333,000		29,221,000
Net collections	$	42,038,000	$	54,158,000
	For the Three Months Ended June 30,
	2013		2012
Gross collections (1)	$	23,432,000	$	28,023,000
Less: commissions and fees (2)		8,007,000		9,548,000
Net collections	$	15,425,000	$	18,475,000

(1) Gross collections include: collections by third-party collection agencies and attorneys, collections from our internal efforts and collections represented by account sales.

(2) Commissions and fees are the contractual commission earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. Includes a 3% fee charged by a servicer on gross collections in connection with the Portfolio Purchase. Such arrangement was consummated in December 2007. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Reclassification for unrealized net gains on available for sale securities	$ 17,000	$ 134,000	$ 192,000	$ 251,000

XML

Summary of Restricted Stock Transactions (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at the beginning of period, Shares	102,321	10,922	10,922	21,843
Awards granted, Shares			102,321
Vested, Shares			(10,922)	(10,921)
Forfeited, Shares
Unvested at the end of period, Shares	102,321	10,922	102,321	10,922
Unvested at the beginning of period, Weighted Average Grant Date Fair Value	$ 9.57	$ 7.63	$ 7.63	$ 7.63
Awards granted, Weighted Average Grant Date Fair Value			$ 9.57
Vested, Weighted Average Grant Date Fair Value			$ 7.63	$ 7.63
Forfeited, Weighted Average Grant Date Fair Value
Unvested at the end of period, Weighted Average Grant Date Fair Value	$ 9.57	$ 7.63	$ 9.57	$ 7.63

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2013	Sep. 30, 2012
ASSETS
Cash and cash equivalents	$ 38,252,000	$ 4,953,000
Investments:
Available-for-sale	58,336,000	58,712,000
Certificates of deposit	8,764,000	42,682,000
Restricted cash	1,067,000	1,088,000
Consumer receivables acquired for liquidation (at net realizable value)	62,594,000	86,887,000
Other investments, net	32,297,000	18,596,000
Due from third party collection agencies and attorneys	1,240,000	2,042,000
Prepaid and income taxes receivable	1,675,000	2,057,000
Furniture and equipment, net	1,096,000	821,000
Deferred income taxes, net	10,944,000	10,410,000
Other assets	7,285,000	4,916,000
Total assets	223,550,000	233,164,000
LIABILITIES
Non-Recourse Debt	54,250,000	61,463,000
Other liabilities	1,816,000	2,920,000
Dividends payable		260,000
Total liabilities	56,066,000	64,643,000
Commitments and contingencies
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding - none
Common stock, $.01 par value; authorized 30,000,000 shares; issued - 14,910,777 at June 30, 2013 and 14,778,956 at September 30, 2012; and outstanding - 12,967,039 at June 30, 2013 and 13,006,918 at September 30, 2012	149,000	148,000
Additional paid-in capital	78,624,000	77,024,000
Retained earnings	107,006,000	107,303,000
Accumulated other comprehensive (loss) income, net of tax	(697,000)	241,000
Treasury stock (at cost) 1,943,738 shares at June 30, 2013 and 1,772,038 shares at September 30, 2012	(17,805,000)	(16,226,000)
Non-controlling interest	207,000	31,000
Total stockholders' equity	167,484,000	168,521,000
Total liabilities and stockholders' equity	$ 223,550,000	$ 233,164,000

XML

Computation of Basic and Diluted Per Share Data (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Schedule Of Computation Of Basic And Diluted Earnings Per Common Share [Line Items]
Basic, Net Income	$ (2,737,000)	$ 3,048,000	$ 733,000	$ 8,485,000
Effect of Dilutive Stock, Net Income
Effect of Dilutive Stock
Diluted, Net income	$ (2,737,000)	$ 3,048,000	$ 733,000	$ 8,485,000
Basic, Weighted Average Shares	12,954,455	14,170,575	12,946,521	14,440,224
Effect of Dilutive Stock, Weighted Average Shares		258,468	271,382	243,417
Diluted, Weighted Average Shares	12,954,455	14,429,043	13,217,903	14,683,641
Basic, per share amount	$ (0.21)	$ 0.22	$ 0.06	$ 0.59
Effect of Dilutive Stock, Per share amount		$ (0.01)		$ (0.01)
Diluted, Per share amount	$ (0.21)	$ 0.21	$ 0.06	$ 0.58

XML

Consumer Receivables Acquired for Liquidation (Tables)

9 Months Ended

Jun. 30, 2013

Changes in Balance Sheet Account of Consumer Receivables Acquired for Liquidation

The following tables summarize the changes in the balance sheet of the investment in receivable portfolios during the following periods.

	For the Nine Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	12,326,000		$	74,561,000		$	86,887,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collection of consumer receivables acquired for liquidation		(26,901,000	)		(13,113,000	)		(40,014,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(987,000	)		(1,037,000	)		(2,024,000	)
Impairment		(2,203,000	)		(10,148,000	)		(12,351,000	)
Finance income recognized (1)		23,531,000			3,225,000			26,756,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		84.4	%		22.8	%		63.6	%

(1) Includes approximately $25.8 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales which occurred in the third quarter.

	For the Nine Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	31,193,000		$	84,002,000		$	115,195,000
Acquisitions of receivable portfolios		1,278,000			1,397,000			2,675,000
Net cash collections from collection of consumer receivables acquired for liquidation		(38,550,000	)		(15,519,000	)		(54,069,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(89,000	)		—			(89,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(733,000	)		—			(733,000	)
Finance income recognized (1)		28,641,000			2,120,000			30,761,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		74.1	%		13.7	%		56.8	%

(1) Includes approximately $27.4 million derived from fully amortized portfolios.

	For the Three Months Ended June 30, 2013
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	6,813,000		$	68,011,000		$	74,824,000
Acquisitions of receivable portfolios		3,340,000			—			3,340,000
Net cash collections from collections of consumer receivables acquired for liquidation		(8,611,000	)		(4,807,000	)		(13,418,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(970,000	)		(1,037,000	)		(2,007,000	)
Impairment		—			(10,148,000	)		(10,148,000	)
Finance income recognized (1)		8,534,000			1,469,000			10,003,000
Balance, end of period	$	9,106,000		$	53,488,000		$	62,594,000
Finance income as a percentage of collections		89.1	%		25.1	%		64.8	%

(1) Includes approximately $9.7 million derived from fully amortized portfolios. Included in finance income derived from fully amortized portfolios is approximately $1.6 million from account sales.

	For the Three Months Ended June 30, 2012
	Interest Method			Cost Recovery Method			Total
Balance, beginning of period	$	24,897,000		$	76,939,000		$	101,836,000
Net cash collections from collections of consumer receivables acquired for liquidation		(12,672,000	)		(5,792,000	)		(18,464,000	)
Cash collections represented by account sales of consumer receivables acquired for liquidation		(11,000	)		—			(11,000	)
Transfer to cost recovery		(6,484,000	)		6,484,000			—
Impairment		(122,000	)		—			(122,000	)
Finance income recognized (1)		9,648,000			853,000			10,501,000
Balance, end of period	$	15,256,000		$	78,484,000		$	93,740,000
Finance income as a percentage of collections		76.1	%		14.7	%		56.8	%

(1) Includes approximately $9.6 million derived from fully amortized portfolios.

Net Cash Collections, Applied to Principal for Interest Method Portfolios

Based upon current projections, net cash collections applied to principal for interest method portfolios will be as follows for the twelve months in the periods ending:

September 30, 2013 (three months ending)	$	2,294,000
September 30, 2014		3,389,000
September 30, 2015		952,000
September 30, 2016		736,000
September 30, 2017		576,000
September 30, 2018		485,000
September 30, 2019		420,000
September 30, 2020		254,000
Total	$	9,106,000

Changes in Accretable Yield

Changes in accretable yield for the nine months and three months ended June 30, 2013 and 2012 are as follows:

	For the Nine Months Ended June 30,
	2013			2012
Balance at beginning of period	$	2,086,000		$	7,473,000
Income recognized on finance receivables		(23,531,000	)		(28,536,000	)
Additions representing expected revenue from purchases		983,000			362,000
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		21,874,000			25,880,000
Balance at end of period	$	1,412,000		$	3,339,000
	For the Three Months Ended June 30,
	2013			2012
Balance at beginning of period	$	942,000		$	6,107,000
Income recognized on finance receivables		(8,534,000	)		(9,543,000	)
Additions representing expected revenue from purchases		983,000			—
Transfer to cost recovery		—			(1,840,000	)
Reclassifications from nonaccretable difference		8,021,000			8,615,000
Balance at end of period	$	1,412,000		$	3,339,000

Collections on Gross Basis Less Commissions and Fees

The following table summarizes collections on a gross basis less commissions and fees for the nine and three month periods ended June 30, 2013 and 2012, respectively:

	For the Nine Months Ended June 30,
	2013		2012
Gross collections (1)	$	66,371,000	$	83,379,000
Less: commissions and fees (2)		24,333,000		29,221,000
Net collections	$	42,038,000	$	54,158,000
	For the Three Months Ended June 30,
	2013		2012
Gross collections (1)	$	23,432,000	$	28,023,000
Less: commissions and fees (2)		8,007,000		9,548,000
Net collections	$	15,425,000	$	18,475,000

(1) Gross collections include: collections by third-party collection agencies and attorneys, collections from our internal efforts and collections represented by account sales.

(2) Commissions and fees are the contractual commission earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. Includes a 3% fee charged by a servicer on gross collections in connection with the Portfolio Purchase. Such arrangement was consummated in December 2007. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

XML

Stock Option Plans

9 Months Ended

Jun. 30, 2013

Stock Option Plans

Note 13: Stock Option Plans

2012 Stock Option and Performance Award Compensation Plan

On February 7, 2012, the Board of Directors adopted the Company’s 2012 Stock Option and Performance Award Compensation Plan (the “2012 Plan”), which was approved by the stockholders of the Company on March 21, 2012. The 2012 Plan replaces the Equity Compensation Plan (as defined below).

The 2012 Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted and unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

The Company authorized 2,000,000 shares of Common Stock for issuance under the 2012 Plan. In December 2012, the Company granted options to purchase shares of the Company and an award of restricted stock totaling 262,321 shares. Additionally, the Company granted options to purchase 50,000 shares of the Company to non-executive employees in June 2013, leaving 1,687,679 shares available as of June 30, 2013. As of June 30, 2013, approximately 58 of the Company’s employees were eligible to participate in the 2012 Plan.

Equity Compensation Plan

On December 1, 2005, the Board of Directors adopted the Company’s Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on March 1, 2006. The Equity Compensation Plan was adopted to supplement the Company’s existing 2002 Stock Option Plan (as defined below).

In addition to permitting the grant of stock options as permitted under the 2002 Stock Option Plan, the Equity Compensation Plan allowed the Company flexibility with respect to equity awards by also providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights.

The Company authorized 1,000,000 shares of Common Stock for issuance under the Equity Compensation Plan. As of March 21, 2012, no more options could be issued under this plan.

2002 Stock Option Plan

On March 5, 2002, the Board of Directors adopted the Company’s 2002 Stock Option Plan (the “2002 Plan”), which plan was approved by the Company’s stockholders on May 1, 2002. The 2002 Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company.

The 2002 Plan authorized the granting of incentive stock options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or not employees) and consultants of the Company.

The Company authorized 1,000,000 shares of Common Stock for issuance under the 2002 Plan. As of March 5, 2012, no more options could be issued under this plan.

1995 Stock Option Plan

In 1995, the Board of Directors adopted the Company’s 1995 Stock Option Plan (the “1995 Plan”), which expired on September 14, 2005. The Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company.

The Company authorized 1,840,000 shares of Common Stock for issuance under the 1995 Plan. As of September 14, 2005, no more awards could be issued under this plan.

The following table summarizes stock option transactions under the plans:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,499,471		$	11.27		1,294,271		$	11.41
Options granted		210,000			9.36		360,000			7.87
Options exercised		(29,500	)		3.51		(19,333	)		3.15
Options forfeited		—			—		(8,300	)		6.02
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,655,871		$	11.12		1,649,538		$	10.64
Options granted		50,000			8.69		—			—
Options exercised		(25,900	)		3.06		(16,000	)		2.95
Options forfeited		—			—		(6,900	)		6.05
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00

The Company recognized $1,307,000 and $532,000 of compensation expense related to stock options during the nine month and three month periods ended June 30, 2013, respectively. Included in stock compensation expense in the nine and three month periods ended June 30, 2013 is approximately $161,000 for non-vested options cancelled during the third quarter of fiscal year 2013. The option awards were not replaced. The Company recognized $1,117,000 and $416,000 of compensation expense related to stock options during the nine month and three month periods ended June 30, 2012, respectively. As of June 30, 2013, there was $2,378,000 of unrecognized compensation expense related to stock option awards. The weighted average remaining period over which such costs are expected to be recognized is 2.0 years. The intrinsic value of the outstanding and exercisable options as of June 30, 2013 was approximately $810,000 and $573,000, respectively. The intrinsic value of the stock options exercised during the nine and three month periods ended June 30, 2013 was approximately $172,000 and $161,000, respectively. The fair value of the stock options exercised during the nine and three month periods ended June 30, 2013 was approximately $276,000 and $241,000, respectively. The weighted average remaining contractual life of exercisable options is 4.1 years. The fair value of the stock options that vested during the nine and three months ended June 30, 2013 was approximately $1,259,000 and $144,000, respectively.

The following table summarizes information outstanding options under the plans as of June 30, 2013:

	Options Outstanding						Options Exercisable
Range of Exercise Price	Number Outstanding		Weighted Average Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$2.8751 – $5.7500		25,800		5.9	$	2.95		25,800	$	2.95
$5.7501 – $8.6250		790,900		7.7		7.81		482,966		7.77
$8.6251 – $14.3750		260,000		9.3		9.28		50,000		11.50
$14.3751 – $17.2500		198,611		0.4		14.88		198,611		14.88
$17.2501 – $20.1250		339,660		1.3		18.23		339,660		18.23
$25.8751 – $28.7500		15,000		3.5		28.75		15,000		28.75
		1,629,971		5.6	$	11.27		1,112,037	$	12.57

The following table summarizes information about restricted stock transactions:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		10,922		$	7.63		21,843		$	7.63
Awards granted		102,321			9.57		—			—
Vested		(10,922	)		7.63		(10,921	)		7.63
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		102,321		$	9.57		10,922		$	7.63
Awards granted		—			—		—			—
Vested		—			—		—			—
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63

The Company recognized $191,000 and $81,000 of compensation expense related to the restricted stock awards during the nine and three month periods ended June 30, 2013, respectively. The Company recognized $64,000 and $21,000 of compensation expense related to restricted stock awards during the nine and three month periods ended June 30, 2012, respectively. As of June 30, 2013, there was $805,000 of unrecognized compensation cost related to unvested restricted stock. The weighted average remaining period over which such costs are recognized is 2.5 years.

XML

Collections on Gross Basis Less Commissions And Fees (Detail) (USD $)	3 Months Ended				9 Months Ended
	Jun. 30, 2013		Jun. 30, 2012		Jun. 30, 2013		Jun. 30, 2012
Consumer Receivables Acquired For Liquidation [Line Items]
Gross collections	$ 23,432,000	[1]	$ 28,023,000	[1]	$ 66,371,000	[1]	$ 83,379,000	[1]
Less: commissions and fees	8,007,000	[2]	9,548,000	[2]	24,333,000	[2]	29,221,000	[2]
Net collections	$ 15,425,000		$ 18,475,000		$ 42,038,000		$ 54,158,000

[1] Gross collections include: collections by third-party collection agencies and attorneys, collections from our internal efforts and collections represented by account sales.

[2] Commissions and fees are the contractual commission earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. Includes a 3% fee charged by a servicer on gross collections in connection with the Portfolio Purchase. Such arrangement was consummated in December 2007. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

XML

Assumptions Used in Option Pricing Model (Detail)	1 Months Ended	9 Months Ended
	Dec. 31, 2012	Jun. 30, 2013
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Risk-free interest rate	0.16%	0.10%
Expected term (years)	6 years	6 years 2 months 12 days
Expected volatility	101.00%	99.70%
Dividend yield	1.67%	0.92%

XML

Consumer Receivables Acquired for Liquidation - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2012
Consumer Receivables Acquired For Liquidation [Line Items]
Consumer receivables acquired for liquidation using interest method	$ 9,106,000		$ 9,106,000
Consumer receivables acquired for liquidation using cost recovery method	53,500,000		53,500,000
Consumer receivables acquired for liquidation concentrated in one portfolio	46,300,000		46,300,000
Portfolio purchase	300,000,000		300,000,000
Consumer receivables acquired for liquidation (at net realizable value)	62,594,000		62,594,000		86,887,000
Face value of charged-off consumer receivables	53,500,000		53,500,000	6,000,000
Purchased cost of charged-off consumer receivables	$ 3,300,000		$ 3,300,000	$ 2,700,000
Number of portfolio purchases		0

XML

Business and Basis of Presentation - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013 Entity
Basis Of Presentation And Significant Accounting Policies [Line Items]
Number of banks with company cash balance	7
Amount that exceed the balance insured by the FDIC	$ 35.2

XML

Available for Sale (Detail) (USD $)	9 Months Ended	12 Months Ended
	Jun. 30, 2013	Sep. 30, 2012
Schedule of Available-for-sale Securities [Line Items]
Cost	$ 55,489,000	$ 58,308,000
Unrealized Gains		404,000
Unrealized Losses	(1,153,000)
Fair Value	$ 58,336,000	$ 58,712,000

XML

Investments

9 Months Ended

Jun. 30, 2013

Investments

Note 3: Investments

Available-for-Sale

Investments classified as available-for-sale at June 30, 2013 and September 30, 2012 consist of the following:

Mutual Funds	Cost		Unrealized Gains		Unrealized Losses			Fair Value
June 30, 2013	$	55,489,000	$	—	$	(1,153,000	)	$	58,336,000
September 30, 2012	$	58,308,000	$	404,000	$	—		$	58,712,000

The available-for-sale investments did not have any contractual maturities. The Company sold three investments during the nine month period ended June 30, 2013, with an aggregate realized gain of $192,000. The Company sold one investment during the three month period ended June 30, 2013, with a realized gain of $17,000. Additionally, the Company received $225,000 in capital gain distribution dividends during the first quarter of fiscal year 2013, which is included in other income. The Company recorded a total of $417,000 in income related to its available-for-sale investments during the first nine months of fiscal year 2013. The Company sold two investments during the nine months ended June 30, 2012, resulting in a realized gain of approximately $251,000.

At June 30, 2013, all six of the Company’s investments were in an unrealized loss position, each of which had current unrealized losses existing for 12 months or less. At September 30, 2012, there were six investments in an unrealized gain position. All of these securities are considered to be acceptable credit risks. Based on the evaluation of the available evidence, including recent changes in market rates and credit rating information, management believes the aggregate decline in fair value of these instruments is temporary. In addition, management has the ability, but does not believe it will be required, to sell these investment securities for a period of time sufficient to allow for an anticipated recovery or maturity. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period in which the other-than-temporary impairment is identified.

Unrealized holding gains and losses on available-for-sale securities are included in other comprehensive income within stockholders’ equity. Realized gains (losses) on available-for-sale securities are included in other income and, when applicable, are reported as a reclassification adjustment in other comprehensive income.

Certificates of Deposit

Certificates of deposit consist of the following:

	June 30,		September 30,
	2013		2012
Certificates of deposit in banks	$	8,764,000	$	42,682,000

Certificates are generally nonnegotiable and nontransferable, and may incur substantial penalties for withdrawal prior to maturity, which will be within one year. The Company liquidated two certificates of deposit of an aggregate of approximately $33,918,000 (plus accrued interest) during the nine month period ended June 30, 2013.

XML

Furniture and Equipment (Tables)

9 Months Ended

Jun. 30, 2013

Furniture and Equipment

Furniture and equipment consist of the following as of the dates indicated:

	June 30, 2013		September 30, 2012
Furniture	$	310,000	$	310,000
Equipment		3,623,000		3,470,000
Software		1,210,000		638,000
Leasehold improvements		99,000		99,000
		5,242,000		4,517,000
Less accumulated depreciation and amortization		4,146,000		3,696,000
	$	1,096,000	$	821,000

XML

Net Cash Collections Applied to Principal for Interest Method Portfolios (Detail) (USD $)	Jun. 30, 2013
Cash, Cash Equivalents and Investments [Line Items]
September 30, 2013 (three months ending)	$ 2,294,000
September 30, 2014	3,389,000
September 30, 2015	952,000
September 30, 2016	736,000
September 30, 2017	576,000
September 30, 2018	485,000
September 30, 2019	420,000
September 30, 2020	254,000
Total	$ 9,106,000

XML

Furniture and Equipment

9 Months Ended

Jun. 30, 2013

Furniture and Equipment

Note 6: Furniture and Equipment

Furniture and equipment consist of the following as of the dates indicated:

	June 30, 2013		September 30, 2012
Furniture	$	310,000	$	310,000
Equipment		3,623,000		3,470,000
Software		1,210,000		638,000
Leasehold improvements		99,000		99,000
		5,242,000		4,517,000
Less accumulated depreciation and amortization		4,146,000		3,696,000
	$	1,096,000	$	821,000

XML

Principles of Consolidation

9 Months Ended

Jun. 30, 2013

Principles of Consolidation

Note 2: Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

XML

Condensed Consolidated Statements of Comprehensive (Loss) Income (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net unrealized securities (loss) gain,(taxes)/tax benefit	$ 415,000	$ (74,000)	$ 543,000	$ (337,000)
Reclassification adjustments for securities,(taxes)/tax benefit	$ 5,000	$ 54,000	$ 76,000	$ 101,000

XML

Net Income Per Share Attributable to Asta Funding Inc - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Computation Of Earnings Per Share Line Items
Shares excluded from diluted earnings per share calculation	554,890	1,283,875	575,669	1,351,492
Weighted average exercise price	$ 9.26	$ 12.02	$ 8.07	$ 11.82

XML

Furniture and Equipment (Detail) (USD $)	Jun. 30, 2013	Sep. 30, 2012
Property, Plant and Equipment [Line Items]
Total	$ 5,242,000	$ 4,517,000
Less accumulated depreciation and amortization	4,146,000	3,696,000
Furniture and equipment, net	1,096,000	821,000
Furniture
Property, Plant and Equipment [Line Items]
Total	310,000	310,000
Equipment
Property, Plant and Equipment [Line Items]
Total	3,623,000	3,470,000
Software
Property, Plant and Equipment [Line Items]
Total	1,210,000	638,000
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Total	$ 99,000	$ 99,000

XML

Stock Option Plans (Tables)

9 Months Ended

Jun. 30, 2013

Stock Option Transactions

The following table summarizes stock option transactions under the plans:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,499,471		$	11.27		1,294,271		$	11.41
Options granted		210,000			9.36		360,000			7.87
Options exercised		(29,500	)		3.51		(19,333	)		3.15
Options forfeited		—			—		(8,300	)		6.02
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		1,655,871		$	11.12		1,649,538		$	10.64
Options granted		50,000			8.69		—			—
Options exercised		(25,900	)		3.06		(16,000	)		2.95
Options forfeited		—			—		(6,900	)		6.05
Options cancelled		(50,000	)		7.77		—			—
Outstanding options at the end of period		1,629,971		$	11.27		1,626,638		$	10.75
Exercisable options at the end of period		1,112,037		$	12.57		1,126,871		$	12.00

Summary of Outstanding Options

The following table summarizes information outstanding options under the plans as of June 30, 2013:

	Options Outstanding						Options Exercisable
Range of Exercise Price	Number Outstanding		Weighted Average Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$2.8751 – $5.7500		25,800		5.9	$	2.95		25,800	$	2.95
$5.7501 – $8.6250		790,900		7.7		7.81		482,966		7.77
$8.6251 – $14.3750		260,000		9.3		9.28		50,000		11.50
$14.3751 – $17.2500		198,611		0.4		14.88		198,611		14.88
$17.2501 – $20.1250		339,660		1.3		18.23		339,660		18.23
$25.8751 – $28.7500		15,000		3.5		28.75		15,000		28.75
		1,629,971		5.6	$	11.27		1,112,037	$	12.57

Summary of Restricted Stock Transactions

The following table summarizes information about restricted stock transactions:

	Nine Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		10,922		$	7.63		21,843		$	7.63
Awards granted		102,321			9.57		—			—
Vested		(10,922	)		7.63		(10,921	)		7.63
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63
	Three Months Ended June 30,
	2013					2012
	Shares			Weighted Average Grant Date Fair Value		Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		102,321		$	9.57		10,922		$	7.63
Awards granted		—			—		—			—
Vested		—			—		—			—
Forfeited		—			—		—			—
Unvested at the end of period		102,321		$	9.57		10,922		$	7.63

XML

Stockholder's Equity - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended			3 Months Ended	1 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2012	Mar. 31, 2013 Share Repurchase Plan	Jun. 30, 2012 Additional Stock	Jun. 30, 2013 Pegasus
Stockholders Equity Note [Line Items]
Cash dividends		$ 1,030,000
Dividend per share		$ 0.08
Stock repurchase program authorized amount	20,000,000
Treasury stock						885,000	1,000,000
Aggregate cost			1,579,000	13,106,000		7,948,000	9,400,000
Other comprehensive income (loss)			$ (697,000)		$ 241,000			$ 207,000

XML

Income Recognition and Impairments

9 Months Ended

Jun. 30, 2013

Income Recognition and Impairments

Note 9: Income Recognition and Impairments

Income Recognition

The Company accounts for its investment in consumer receivables acquired for liquidation using the interest method under the guidance of ASC 310. In ASC 310 static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision.

Once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller). ASC 310 requires that the excess of the contractual cash flows over expected cash flows not be recognized as an adjustment of revenue or expense or on the balance sheet. ASC 310 initially freezes the IRR, estimated when the accounts receivable are purchased, as the basis for subsequent impairment testing. Significant increases in actual, or expected future cash flows may be recognized prospectively through an upward adjustment of the IRR over a portfolio’s remaining life. Any increase to the IRR then becomes the new benchmark for impairment testing. Under ASC 310, rather than lowering the estimated IRR if the collection estimates are not received or projected to be received, the carrying value of a pool would be written down to maintain the then current IRR.

Finance income is recognized on cost recovery portfolios after the carrying value has been fully recovered through collections or amounts written down.

The Company accounts for its investment in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse.

When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

The funding of BPCM matrimonial actions is on a non-recourse basis. BPCM revenues are recognized under the cost recovery method.

Impairments

The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. Increases in expected cash flows are recognized prospectively through an adjustment of the IRR while decreases in expected cash flows are recognized as impairments. ASC 310 makes it more likely that impairment losses and accretable yield adjustments for portfolios’ performances which exceed original collection projections will be recorded, as all downward revisions in collection estimates will result in impairment charges, given the requirement that the IRR of the affected pool be held constant. An impairment of $12.3 million and $10.1 million was recorded during the nine and three month periods ended June 30, 2013. An impairment of $733,000 and $122,000 was recorded during the same prior year periods. The impairment recorded in the third quarter of fiscal 2013 was related to the Great Seneca portfolio as revised forecasts deteriorated during the current quarter. Finance income is not recognized on cost recovery method portfolios until the cost of the portfolio is fully recovered. Collection projections are performed on both interest method and cost recovery method portfolios. With regard to the cost recovery portfolios, if collection projections indicate the carrying value will not be recovered, a write down in value is required.

The Company’s analysis of the timing and amount of cash flows to be generated by our portfolio purchases are based on the following attributes:

• the type of receivable, the location of the debtor and the number of collection agencies previously attempting to collect the receivables in the portfolio. The Company has found that there are better states to try to collect receivables and it factors in both better and worse states when establishing its initial cash flow expectations;

• the average balance of the receivables influences the Company’s analysis in that lower average balance portfolios tend to be more collectible in the short-term and higher average balance portfolios are more appropriate for our lawsuit strategy and thus yield better results over the longer term. As the Company has significant experience with both types of balances, it is able to factor these variables into its initial expected cash flows;

• the age of the receivables, the number of days since charge-off, any payments since charge-off, and the credit guidelines of the credit originator also represent factors taken into consideration in our estimation process. For example, older receivables might be more difficult and/or require more time and effort to collect;

• past history and performance of similar assets acquired. As the Company purchases portfolios of like assets, it accumulates a significant historical database on the tendencies of debtor repayments and factors this into its initial expected cash flows;

• the Company’s ability to analyze accounts and resell accounts that meet its criteria;

• jobs or property of the debtors found within portfolios. With the Company’s business model, this is of particular importance. Debtors with jobs or property are more likely to repay their obligation through the lawsuit strategy and, conversely, debtors without jobs or property are less likely to repay their obligation. The Company believes that debtors with jobs or property are more likely to repay because courts have mandated the debtor must pay the debt. Ultimately, the debtor will pay to clear title or release a lien. The Company also believes that these debtors generally might take longer to repay and that is factored into its initial expected cash flows; and

• credit standards of issuer.

The Company acquires accounts that have experienced deterioration of credit quality between origination and the date of its acquisition of the accounts. The amount paid for a portfolio of accounts reflects the Company’s determination that it is probable that the Company will be unable to collect all amounts due according to the portfolio of accounts’ contractual terms. The Company considers the expected payments and estimates the amount and timing of undiscounted expected principal, interest and other cash flows for each acquired portfolio, coupled with expected cash flows from accounts available for sale. The excess of this amount over the cost of the portfolio, representing the excess of the accounts’ cash flows expected to be collected over the amount paid, is accreted into income recognized on finance receivables, and accounted for on the interest method over the expected remaining life of the portfolio.

The Company believes it has extensive experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying debtors. The Company acquires these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid, so that the Company believes that its estimated cash flow offers it an adequate return on its acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, the Company has the added benefit of soliciting its third party servicers for their input with respect to liquidation rates and, at times, incorporates such input into the estimates that the Company uses for its expected cash flows.

As a result of the challenging economic environment and the impact it has had on the collections, for portfolio purchases acquired since the beginning of fiscal year 2009, the Company has extended its time frame of the expectation of recovering 100% of the invested capital to within a 24-29 month period from an 18-28 month period, and the expectation of recovering 130-140% of invested capital to a period of 7 years, an increase from the previous 5-year expectation. The medical accounts are accounted for using the cost recovery method. The Company routinely monitors these expectations against the actual cash flows and, in the event the cash flows are below its expectations and it believes that there are no reasons relating to mere timing differences or explainable delays (such as can occur, particularly when the court system is involved) for the reduced collections, an impairment would be recorded as a provision for credit losses. Conversely, in the event the cash flows are in excess of its expectations and the reason is due to timing, the Company would defer the “excess” collection as deferred revenue.

Commissions and Fees

Commissions and fees are the contractual commissions earned by third party collection agencies and attorneys, and direct costs associated with the collection effort; generally court costs. The Company expects to continue to purchase portfolios and utilize third party collection agencies and attorney networks.

XML

Other Investments

9 Months Ended

Jun. 30, 2013

Other Investments

Note 5: Other Investments

Personal Injury Claims

On December 28, 2011, the Company, through an indirect subsidiary, APH, entered into a joint venture with Pegasus Legal Funding LLC (“PLF”) in the operating subsidiary of Pegasus. Pegasus purchases interests in claims from claimants who are a party to a personal injury litigation, with the expectation of a settlement in the future. Pegasus advances, to each claimant, funds, on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company, through Pegasus, earned $2.3 million and $4.9 million, respectively, in interest and fees for the three and nine month periods ended June 30, 2013, compared to $0.4 million and $1.0 million for the three and nine month periods ended June 30, 2012. The Company had a net invested balance of $32.3 million on June 30, 2013 and a $13.0 million net invested balance on June 30, 2012. The collections yielded net income attributable to non-controlling interest of $176,000 and $53,000, respectively, for the nine and three month periods ended June 30, 2013, compared to $66,000 and $17,000, respectively, for the nine and three month periods ended June 30, 2012.

Matrimonial Claims (included in Other Assets)

On May 18, 2012, the Company formed BP Case Management, LLC (“BPCM”), a joint venture with California-based Balance Point Divorce Funding LLC (“BP Divorce Funding”). BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provides a $1.0 million revolving line of credit to partially fund BP Divorce Funding’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of twenty-four months. The revolving line of credit is collateralized by BP Divorce Funding’s profit share in BPCM and other assets. As of June 30, 2013, the Company’s investment in cases through BPCM was approximately $989,000. The Company recognized $0 in revenue for the three month periods ended June 30, 2013 and 2012. The Company recognized $0 in revenue for the nine month period ended June 30, 2013 compared to $165,000 for the nine month period ended June 30, 2012.

XML

Stock Based Compensation

9 Months Ended

Jun. 30, 2013

Stock Based Compensation

Note 12: Stock Based Compensation

The Company accounts for stock-based employee compensation under ASC 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires that compensation expense associated with stock options and other stock based awards be recognized in the statement of income, rather than a disclosure in the notes to the Company’s consolidated financial statements.

In June 2013, through a previous action of the Compensation Committee of the Board of Directors of the Company (“Compensation Committee”) authorizing the Chief Executive Officer of the Company the discretion to grant stock option awards to non-officer employees, the Chief Executive Officer awarded 50,000 stock options to non-officer employees. The exercise price of these options, issued on June 13, 2013, was equal to the market price on that date. The options vest in three equal installments, accounted for as one graded vesting award, starting on the first anniversary of the grant. The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.10	%
Expected term (years)	6.2
Expected volatility	99.7	%
Dividend yield	0.92	%

In December 2012, the Compensation Committee granted 160,000 stock options, of which 65,000 options were awarded to three officers of the Company and 20,000 options were awarded to an employee of the Company. The remaining 75,000 shares were issued to six non-employee directors of the Company. The exercise price of these options, issued on December 18, was equal to the market price on that date. The options vest in three equal installments, accounted for as one graded vesting award, starting on the first anniversary of the grant. The assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.16	%
Expected term (years)	6.0
Expected volatility	101.0	%
Dividend yield	1.67	%

In addition, the Company granted 102,321 restricted shares to the Chief Executive Officer of the Company. The shares vest in three equal installments, starting on the first anniversary of the grant.

XML

Income Taxes

9 Months Ended

Jun. 30, 2013

Income Taxes

Note 10: Income Taxes

Deferred federal and state taxes principally arise from (i) recognition of finance income collected for tax purposes, but not yet recognized for financial reporting; (ii) provision for impairments/credit losses; and (iii) stock based compensation expense for stock option grants and restricted stock awards recorded in the statement of income for which no cash distribution has been made. Other components consist of state net operating loss (“NOL”) carry-forwards. The provision for income tax expense for the three month periods ended June 30, 2013 and 2012, respectively, reflects income tax (benefit) expense at an effective rate of (40.9)% and 40.3%. The provision for income tax expense for the nine month periods ended June 30, 2013 and 2012, respectively, reflects income tax expense at an effective rate of 40.5 % and 40.3%.

The corporate federal income tax returns of the Company for 2009, 2010, 2011 and 2012 are subject to examination by the IRS, generally for three years after they are filed. The state income tax returns and other state filings of the Company are subject to examination by the state taxing authorities, for various periods, generally up to four years after they are filed.

In April 2010, the Company received notification from the IRS that the Company’s 2008, 2009 and 2010 federal income tax returns would be audited. This audit is currently in progress.

XML

Document and Entity Information	9 Months Ended
	Jun. 30, 2013	Aug. 05, 2013
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Trading Symbol	ASFI
Entity Registrant Name	ASTA FUNDING INC
Entity Central Index Key	0001001258
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		12,967,039

XML

Net Income (Loss) per Share Attributable to Asta Funding, Inc.

9 Months Ended

Jun. 30, 2013

Net Income (Loss) per Share Attributable to Asta Funding, Inc.

Note 11: Net Income (Loss) per Share Attributable to Asta Funding, Inc.

Basic per share data is determined by dividing net income by the weighted average shares outstanding during the period. Diluted per share data is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. With respect to the assumed proceeds from the exercise of dilutive options, the treasury stock method is calculated using the average market price for the period.

The following table presents the computation of basic and diluted per share data for the nine and three months ended June 30, 2013 and 2012:

	Nine Months Ended June 30,
	2013						2012
	Net Income		Weighted Average Shares		Per Share Amount		Net Income		Weighted Average Shares		Per Share Amount
Basic	$	733,000		12,946,521	$	0.06	$	8,485,000		14,440,224	$	0.59
Effect of Dilutive Stock		—		271,382		—		—		243,417		(0.01	)
Diluted	$	733,000		13,217,903	$	0.06	$	8,485,000		14,683,641	$	0.58

At June 30, 2013, options to purchase 575,669 shares at a weighted average exercise price of $8.07 were not included in the diluted earnings per share calculation for the nine month period ended June 30, 2013 as they were anti-dilutive.

At June 30, 2012, options to purchase 1,351,492 shares at a weighted average exercise price of $11.82 were not included in the diluted earnings per share calculation for the nine month period ended June 30, 2012 as they were anti-dilutive.

	Three Months Ended June 30,
	2013								2012
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Basic	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,170,575	$	0.22
Effect of Dilutive Stock		—			—		—			—		258,468		(0.01	)
Diluted	$	(2,737,000	)		12,954,455	$	(0.21	)	$	3,048,000		14,429,043	$	0.21

At June 30, 2013, options to purchase 554,890 shares at a weighted average exercise price of $9.26 were not included in the diluted earnings per share calculation for the three month period ended June 30, 2013 as they were anti-dilutive.

At June 30, 2012, options to purchase 1,283,875 shares at a weighted average exercise price of $12.02 were not included in the diluted earnings per share calculation for the three month period ended June 30, 2012 as they were anti-dilutive.

XML

Subsequent Event - Additional Information (Detail) (Subsequent Event, USD $) In Millions, unless otherwise specified	1 Months Ended
	Aug. 07, 2013
Subsequent Event
Subsequent Event [Line Items]
Prepayment fund	$ 15
BMO right to receive from future net collections	30.00%

XML

Fair Value of Financial Measurements (Detail) (USD $)	Jun. 30, 2013	Sep. 30, 2012
Financial assets
Available-for-sale investments	$ 58,336,000	$ 58,712,000
Certificates of deposit	8,764,000	42,682,000
Financial liabilities
Non-Recourse Debt	54,250,000	61,463,000
Carrying Amount | Level 1
Financial assets
Available-for-sale investments	58,336,000	58,712,000
Carrying Amount | Level 2
Financial assets
Certificates of deposit	8,764,000	42,682,000
Financial liabilities
Non-Recourse Debt	54,250,000	61,463,000
Carrying Amount | Level 3
Financial assets
Consumer receivables acquired for liquidation	62,594,000	86,887,000
Fair Value | Level 1
Financial assets
Available-for-sale investments	58,336,000	58,712,000
Certificates of deposit	8,764,000	42,682,000
Fair Value | Level 2
Financial liabilities
Non-Recourse Debt	28,000,000	61,463,000
Fair Value | Level 3
Financial assets
Consumer receivables acquired for liquidation	$ 82,887,000	$ 100,706,000